UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q
 
x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended June 26, 2015July 1, 2016
or
¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from ____ to ____
 
Commission File Number 0-6508001-34376
 
IEC ELECTRONICS CORP.
(Exact name of registrant as specified in its charter)
 
Delaware 13-3458955
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)   
 
105 Norton Street, Newark, New York   14513
(Address of Principal Executive Offices) (Zip Code)
  
315-331-7742
(Registrant's telephone number, including area code)
 
Not Applicable
(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No ¨
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes x No ¨
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer ¨
 
Accelerated filer ¨
Non-accelerated filer ¨
 
Smaller reporting company x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨ No x
 
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:
 
Common Stock, $0.01 par value – 10,188,30810,274,403 shares as of July 31, 2015August 1, 2016






TABLE OF CONTENTS
 
 
 

2





Part I     FINANCIAL INFORMATION
 
Item 1.  Condensed Financial Statements
 
IEC ELECTRONICS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
JUNE 26, 2015JULY 1, 2016 and SEPTEMBER 30, 20142015
(in thousands, except share and per share data)
June 26,
2015
 September 30,
2014
July 1, 2016 September 30, 2015
(unaudited) (restated)(unaudited) 
ASSETS      
Current assets:      
Cash$290
 $1,980
$603
 $407
Accounts receivable, net of allowance21,024
 22,347
19,098
 24,923
Inventories, net27,434
 22,526
20,113
 25,753
Other current assets1,952
 3,597
1,340
 1,444
Total current assets50,700
 50,450
41,154
 52,527

      
Fixed assets, net16,956
 17,850
15,231
 15,443
Intangible assets, net144
 2,392
105
 134
Goodwill101
 2,005
101
 101
Deferred income taxes3
 
Other long term assets161
 299
268
 57

   
Total assets$68,062
 $72,996
$56,862
 $68,262

      
LIABILITIES AND STOCKHOLDERS' EQUITY      
Current liabilities:      
Current portion of long-term debt$14,148
 $2,908
$2,665
 $2,908
Accounts payable17,695
 17,732
13,616
 18,336
Accrued payroll and related expenses2,177
 3,203
3,638
 2,338
Other accrued expenses1,075
 1,008
662
 1,318
Customer deposits5,070
 1,553
3,186
 5,761
Total current liabilities40,165
 26,404
23,767
 30,661

      
Long-term debt18,867
 28,479
18,943
 28,323
Other long-term liabilities584
 708
583
 590
Total liabilities59,616
 55,591
43,293
 59,574

      
STOCKHOLDERS' EQUITY      
Preferred stock, $0.01 par value:
500,000 shares authorized; none issued or outstanding

 

 
Common stock, $0.01 par value:      
Authorized: 50,000,000 shares      
Issued: 11,207,612 and 11,146,571 shares, respectively   
Outstanding: 10,187,808 and 10,126,767 shares, respectively112
 111
Issued: 11,329,891 and 11,232,017 shares, respectively   
Outstanding: 10,274,403 and 10,196,145 shares, respectively113
 112
Additional paid-in capital45,765
 44,302
46,175
 45,845
Retained earnings/(accumulated deficit)(35,902) (25,554)(31,130) (35,740)
Treasury stock, at cost: 1,019,804 shares(1,529) (1,454)
Treasury stock, at cost: 1,055,488 and 1,035,872 shares, respectively(1,589) (1,529)
Total stockholders' equity8,446
 17,405
13,569
 8,688
      
Total liabilities and stockholders' equity$68,062
 $72,996
$56,862
 $68,262

The accompanying notes are an integral part of these condensed consolidated financial statements.

3




IEC ELECTRONICS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS
THREE and NINE MONTHS ENDED JULY 1, 2016 and JUNE 26, 2015 and JUNE 27, 2014
(unaudited; in thousands, except share and per share data)
 
Three Months Ended Nine Months EndedThree Months Ended Nine Months Ended
June 26,
2015
 June 27,
2014
 June 26,
2015

June 27,
2014
July 1,
2016
 June 26,
2015
 July 1,
2016
 June 26,
2015
  (restated)   (restated)   
Net sales$34,444
 $32,992
 $98,276

$99,934
$32,508
 $32,577
 $98,590
 $93,061
Cost of sales29,741
 29,197
 87,757
 88,118
27,045
 27,888
 81,573
 81,944
Gross profit4,703
 3,795
 10,519

11,816
$5,463
 $4,689
 $17,017
 $11,117
              
Selling and administrative expenses4,049
 3,195
 14,346
 10,938
3,463
 3,689
 11,218
 13,255
Impairment of goodwill and other intangibles4,057
 
 4,057
 
Restatement and related expenses298
 102
 948
 2,516
12
 312
 4
 953
Operating profit/(loss)(3,701) 498
 (8,832) (1,638)1,988
 688
 5,795
 (3,091)
              
Interest and financing expense316
 558
 1,516

1,410
389
 316
 1,191
 1,516
Other expense/(income)
 
 

18
Income/(loss) before income taxes(4,017) (60) (10,348) (3,066)
Income/(loss) from continuing operations before income taxes1,599
 372
 4,604
 (4,607)
              
Provision for/(benefit from) income taxes
 
 

13,039
(6) (4) (6) (4)
Income/(loss) from continuing operations1,605
 376
 4,610
 (4,603)
       
Loss on discontinued operations, net
 (4,392) 
 (5,745)
       
Net income/(loss)$(4,017) $(60) $(10,348) $(16,105)$1,605
 $(4,016) $4,610
 $(10,348)
              
Net income/(loss) per common and common equivalent share:  
    
Basic$(0.39) $(0.01) $(1.03) $(1.64)
Diluted(0.39) (0.01) (1.03) (1.64)
Basic net income/(loss) per common and common equivalent share:Basic net income/(loss) per common and common equivalent share:    
Earnings/(loss) from continuing operations$0.16
 $0.04
 $0.45
 $(0.46)
Earnings/(loss) from discontinued operations
 (0.43) $
 $(0.57)
Net earnings/loss$0.16
 $(0.39) $0.45
 $(1.03)
       
Diluted net income/(loss) per common and common equivalent share:       
Earnings/(loss) from continuing operations$0.16
 $0.04
 $0.45
 $(0.46)
Earnings/(loss) from discontinued operations
 (0.43) 
 (0.57)
Net earnings/loss$0.16
 $(0.39) $0.45
 $(1.03)
              
Weighted average number of common and common equivalent shares outstanding:Weighted average number of common and common equivalent shares outstanding:       
    
Basic10,199,431
 9,838,872
 10,049,395
 9,816,974
10,211,347
 10,199,431
 10,210,805
 10,049,395
Diluted10,199,431
 9,838,872
 10,049,395
 9,816,974
10,211,347
 10,199,431
 10,210,805
 10,049,395
 
The accompanying notes are an integral part of these condensed consolidated financial statements.

4





IEC ELECTRONICS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS of CHANGES in STOCKHOLDERS' EQUITY
NINE MONTHS ENDED JULY 1, 2016 and JUNE 26, 2015 and JUNE 27, 2014
(unaudited; in thousands)
 
Common
Stock,
par $0.01

 
Additional
Paid-In
Capital

 Retained Earnings/ (Accumulated Deficit)
 
Treasury
Stock,
at cost

 
Total
Stockholders'
Equity

Common
Stock,
par $0.01

 
Additional
Paid-In
Capital

 Retained Earnings/ (Accumulated Deficit)
 
Treasury
Stock,
at cost

 
Total
Stockholders'
Equity

 
  
 (restated)
  
   
  
    
  
Balances, September 30, 2013$110
 $43,802
 $(10,483) $(1,435) $31,994
Balances, September 30, 2014$111
 $44,302
 $(25,554) $(1,454) $17,405

                  
Net loss
 
 (16,105) 
 (16,105)
 
 (10,348) 
 (10,348)
Stock-based compensation
 378
 
 
 378

 1,990
 
 
 1,990
Restricted (non-vested) stock grants, net of
forfeitures
1
 (1) 
 
 
2
 (2) 
 
 
Exercise of stock options
 32
 
 (15) 17

 78
 
 (75) 3
Shares withheld for payment of taxes upon
vesting of restricted stock

 (79) 
 
 (79)(1) (603) 
 
 (604)

                  
Balances, June 27, 2014, restated$111
 $44,132
 $(26,588) $(1,450) $16,205
Balances, June 26, 2015$112
 $45,765
 $(35,902) $(1,529) $8,446
 
 
Common
Stock,
par $0.01

 
Additional
Paid-In
Capital

 Retained Earnings/ (Accumulated Deficit)
 
Treasury
Stock,
at cost

 
Total
Stockholders'
Equity

          
Balances, September 30, 2014, restated$111
 $44,302
 $(25,554) $(1,454) $17,405

         
Net loss
 
 (10,348) 
 (10,348)
Stock-based compensation
 1,990
 
 
 1,990
Restricted (non-vested) stock grants, net of
    forfeitures
2
 (2) 
 
 
Exercise of stock options
 78
 
 (75) 3
Shares withheld for payment of taxes upon
    vesting of restricted stock
(1) (603) 
 
 (604)

         
Balances, June 26, 2015$112
 $45,765
 $(35,902) $(1,529) $8,446
 
Common
Stock,
par $0.01

 
Additional
Paid-In
Capital

 Retained Earnings/ (Accumulated Deficit)
 
Treasury
Stock,
at cost

 
Total
Stockholders'
Equity

          
Balances, September 30, 2015$112
 $45,845
 $(35,740) $(1,529) $8,688

         
Net income
 
 4,610
 
 4,610
Stock-based compensation
 324
 
 
 324
Restricted (non-vested) stock grants, net of
    forfeitures
1
 (1) 
 
 
Exercise of stock options
 
 
 
 
Employee stock plan purchases
 7
 
 
 7
Return of incentive compensation shares
 
 
 (60) (60)

         
Balances, July 1, 2016$113
 $46,175
 $(31,130) $(1,589) $13,569
 
The accompanying notes are an integral part of these condensed consolidated financial statements.

5




IEC ELECTRONICS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS of CASH FLOWS
NINE MONTHS ENDED JULY 1, 2016 and JUNE 26, 2015 and JUNE 27, 2014
(unaudited; in thousands) 
 Nine Months Ended Nine Months Ended
 June 26,
2015
 June 27,
2014
 July 1,
2016
 June 26,
2015
   (restated)   
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net income/(loss) $(10,348) $(16,105) $4,610
 $(10,348)
Less: Loss on discontinued operations, net 
 (5,745)
Income/(loss) from continuing operations 4,610
 (4,603)
Non-cash adjustments:        
Stock-based compensation 1,990
 378
 324
 1,990
Incentive compensation shares returned (60) 
Depreciation and amortization 3,488
 3,625
 2,432
 2,948
Impairment of goodwill & other intangibles 4,057
 
(Gain)/loss on sale of fixed assets 1
 
Reserve for doubtful accounts (87) 220
 253
 (23)
Provision for excess/obsolete inventory (34) 378
Deferred tax expense/benefit 
 13,034
 (3) 
Changes in assets and liabilities:        
Accounts receivable 1,410
 4,480
 5,572
 1,346
Inventory (4,908) 1,195
 5,674
 (5,563)
Other current assets 947
 (1,497) 104
 888
Other long term assets 130
 81
 3
 130
Accounts payable (59) (2,634) (4,720) (59)
Accrued expenses (959) 541
 644
 (959)
Customer deposits 3,517
 741
 (2,575) 3,293
Other long term liabilities (124) (14) 25
 (124)
Net cash flows from operating activities-continuing operations 12,250
 (358)
Net cash flows from operating activities-discontinued operations 
 (536)
Net cash flows from operating activities (946) 4,045
 12,250
 (894)
        
CASH FLOWS FROM INVESTING ACTIVITIES:        
Purchases of fixed assets (2,469) (3,806) (2,165) (2,495)
Grant proceeds from outside parties 698
 
 
 698
Proceeds from (net cost of) disposal of fixed assets 
 323
Net cash flows from investing activities-continuing operations (2,165) (1,797)
Net cash flows from investing activities-discontinued operations 
 (26)
Net cash flows from investing activities (1,771) (3,483) (2,165) (1,823)
        
CASH FLOWS FROM FINANCING ACTIVITIES:        
Advances from revolving line of credit 49,578
 43,513
 43,116
 49,578
Repayments of revolving line of credit (45,769) (44,971) (50,315) (45,769)
Borrowings under other loan agreements 
 1,300
 
 
Repayments under other loan agreements (2,181) (2,160) (2,456) (2,181)
Debt issuance costs 
 (2) (241) 
Proceeds from exercise of stock options 3
 17
 
 3
Proceeds from employee stock plan purchases 7
 
Shares withheld for payment of taxes upon vesting of restricted stock (604) (79) 
 (604)
Net cash flows from financing activities-continuing operations (9,889) 1,027
Net cash flows from financing activities-discontinued operations 
 
Net cash flows from financing activities 1,027
 (2,382)
(9,889) 1,027
        
Net increase/(decrease) in cash and cash equivalents (1,690) (1,820)
Cash and cash equivalents, beginning of period 1,980
 2,499
Cash and cash equivalents, end of period $290
 $679
    
Supplemental cash flow information:    
Interest paid $1,184
 $1,177
Income taxes paid 
 12
    
Non-cash transactions    
Fixed assets purchased with extended payment terms 22
 466


Net increase/(decrease) in cash and cash equivalents 196
 (1,690)
Cash and cash equivalents, beginning of period 407
 1,980
Cash and cash equivalents, end of period $603
 $290
     
Supplemental cash flow information:    
Interest paid $1,188
 $1,184
Income taxes paid 3
 
     
Non-cash transactions:    
Fixed assets purchased with extended payment terms $
 $22
Incentive compensation shares returned 60
 
The accompanying notes are an integral part of these condensed consolidated financial statements.

6




IEC ELECTRONICS CORP. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
NOTE 1—OUR BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Our Business
 
IEC Electronics Corp. ("IEC"(“IEC”, "we"“we”, "our"“our”, “us”, or the “Company”) is a provider ofprovides electronic contract manufacturing services (“EMS”) to companies in various industries that require advanced technology.  We specialize in the custom manufacture of high reliability, complex circuit boards and system-level assemblies; a wide array of cable and wire harness assemblies capable of withstanding extreme environments; and precision metal components.  We provide EMS where quality and reliability are of paramount importance and when low-to-medium volume, high-mix production is the norm.  We utilize state-of-the-art, automated circuit board assembly equipment together with a full complement of high-reliability manufacturing stress testing methods.  Our customers are at the center of everything we do and we are capable of reacting and adapting to their ever-changing needs.  Our customer-centric approach offers a high degree of flexibility while simultaneously complying with rigorous quality and on-time delivery standards. 
 
Generally Accepted Accounting Principles
 
IEC's financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"(“GAAP”), as set forth in the Financial Accounting Standards Board's (“FASB”) Accounting Standards Codification (“ASC”).
 
Fiscal Calendar
 
The Company’s fiscal year ends on September 30th and the first three quarters end generally on the Friday closest to the last day of the calendar quarter.
 
Consolidation
 
The consolidated financial statements include the accounts of IEC and its wholly owned subsidiaries: IEC Electronics Wire and Cable, Inc. (“Wire and Cable”); IEC Electronics Corp-Albuquerque ("Albuquerque"(“Albuquerque”); and IEC Analysis & Testing Laboratory, LLC (“ATL”), formerly Dynamic Research and Testing Laboratories, LLC (“DRTL”); and Southern California Braiding, Inc. (“SCB”).LLC. The Celmet unit ("Celmet"(“Celmet”) operates as a division of IEC.  As further discussed in Note 2—SCB Divestiture and Discontinued Operations, the operations of our wholly-owned subsidiary, formerly known as Southern California Braiding, Inc. (“SCB”), were divested during the fourth quarter of fiscal 2015.  All significant intercompany transactions and accounts are eliminated in consolidation. 

Unaudited Financial Statements
 
The accompanying unaudited financial statements for the three and nine months ended July 1, 2016 and June 26, 2015 and June 27, 2014 have been prepared in accordance with GAAP for interim financial information.  In the opinion of management, all adjustments required for a fair presentation of the information have been made.  The accompanying financial statements should be read in conjunction with the financial statements and notes included in the Company's Annual Report on Form 10-K/A10-K for the fiscal year ended September 30, 2014.2015.
Reclassifications

Prior year financial statement amounts are reclassified as necessary to conform to the current year presentation, including presentation of results of discontinued operations.
 
Cash and Cash Equivalents
 
The Company'sCompany’s cash and cash equivalents principally represent deposit accounts with Manufacturers and Traders Trust Company ("(“M&T Bank" and "M&T"Bank”), a banking corporation headquartered in Buffalo, NY.
 
Allowance for Doubtful Accounts
 
The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management's evaluation of collectability.  Accounts are written off after all reasonable collection efforts have been exhausted and management concludes that likelihood of collection is remote.
 


Inventory Valuation
 
Inventories are stated at the lower of cost or market value under the first-in, first-out method.  The Company regularly assesses slow-moving, excess and obsolete inventory and maintains balance sheet reserves in amounts required to reduce the recorded value of inventory to lower of cost or market.
 
Property, Plant and Equipment
 
Property, plant and equipment (“PP&E”) are stated at cost and are depreciated over various estimated useful lives using the straight-line method.  Maintenance and repairs are charged to expense as incurred, while renewals and improvements are capitalized.  At the time of retirement or other disposition of PP&E, cost and accumulated depreciation are removed from the accounts and any gain or loss is recorded in earnings.

7



 
Depreciable lives generally used for PP&E are presented in the table below.  Leasehold improvements are amortized over the shorter of the lease term or estimated useful life of the improvement.
PP&E Lives Estimated
Useful Lives
  (years)
Land improvements 10
Buildings and improvements 5 to 40
Machinery and equipment 3 to 5
Furniture and fixtures 3 to 7
 
Intangible Assets
 
Intangible assets (other than goodwill) are those that lack physical substance and are not financial assets.  Such assets held by IEC were acquired in connection with business combinations and the remaining assets represent economic benefits associated with acquired customer relationships, a non-compete agreement, and a property tax abatement.  Values assigned to individual intangible assets are amortized using the straight-line method over their estimated useful lives. 
 
Reviewing Long-Lived Assets for Potential Impairment
 
TheASC 360-10 (Property, Plant and Equipment) and ASC 350-30 (Intangibles) require the Company teststo test long-lived assets (PP&E and definitive-liveddefinitive lived assets) for recoverability whenever events or circumstances indicate that the carrying amount of the asset may not be recoverable.  If the carrying value of an asset exceeds the undiscounted future cash flows attributable to an asset, it is considered impaired and the excess of carrying value over fair value must be charged to earnings.  No impairment charges were recorded by IEC for property, plant and equipment or intangibles in fiscal 2016.
 
Goodwill
 
Goodwill represents the excess of cost over fair value of net assets acquired in a business combination.   Historically, most of IEC's recordedUnder ASC 350, goodwill related to SCB, which was acquired in December 2010. A lesser portion relates to Celmet, which was acquired in July 2010.  

Goodwill is not amortized but is reviewed for impairment at least annually or when events or circumstances indicate that carrying value may exceed fair value.  The Company performs its annual impairment test for SCB goodwill during the third quarter.  The Company may elect to precede a quantitative review for impairment with a qualitative assessment of the likelihood that fair value of a particular reporting unit exceeds carrying value.  If the qualitative assessment leads to a conclusion that it is more than 50 percent likely that fair value of the reporting units exceeds its carrying value, then no further testing is required.  In the event of a less favorable outcome, the Company is required to proceed with quantitative testing. 

The quantitative process entails comparing the overall fair value of the unit to which goodwill relates to its carrying value.  If the fair value of the unit exceeds its carrying value, no further assessment of potential impairment is required.  If the fair value of the unit is less than its carrying value, a valuation of the unit'sunit’s individual assets and liabilities is required to determine whether or not goodwill is impaired.  Goodwill impairment losses are charged to earnings. 
 
IEC’s remaining goodwill relates to Celmet, which was acquired in July 2010.  



Leases
At the inception of a lease covering equipment or real estate, the lease agreement is evaluated under criteria discussed in ASC 840-10-25 (Leases).  Leases meeting one of four key criteria are accounted for as capital leases and all others are treated as operating leases.  Under a capital lease, the discounted value of future lease payments becomes the basis for recognizing an asset and a borrowing, and lease payments are allocated between debt reduction and interest.  For operating leases, payments are recorded as rent expense.  Criteria for a capital lease include (i) transfer of ownership during the lease term; (ii) existence of a bargain purchase option under terms that make it likely to be exercised; (iii) a lease term equal to 75 percent or more of the economic life of the leased property; and (iv) minimum lease payments that equal or exceed 90 percent of the fair value of the property.

Legal Contingencies
 
When legal proceedings are brought or claims are made against us and the outcome is uncertain, ASC 450-10 (Contingencies) requires that we determine whether it is probable that an asset has been impaired or a liability has been incurred.  If such impairment or liability is probable and the amount of loss can be reasonably estimated, the loss must be charged to earnings. 
 
When it is considered probable that a loss has been incurred, but the amount of loss cannot be estimated, disclosure but not accrual of the probable loss is required.  Disclosure of a loss contingency is also required when it is reasonably possible, but not probable, that a loss has been incurred. 

Customer Deposits

Customer deposits represent amounts invoiced to customers for which the revenue has not yet been earned and therefore represent a commitment for the Company to deliver goods or services in the future. Deposits are generally short term in nature and are recognized as revenue when earned.

8



 
Grants from Outside Parties
 
Grants from outside parties are recorded as other long-term liabilities and are amortized over the same period during which the associated fixed assets are depreciated.
 
Derivative Financial Instruments
 
The Company actively monitors its exposure to interest rate risk and from time to time uses derivative financial instruments to manage the impact of this risk.  The Company uses derivatives only for purposes of managing risk associated with underlying exposures.  The Company does not trade or use instruments with the objective of earning financial gains on the interest rate, nor does the Company use derivative instruments where it does not have underlying exposures.  The Company manages its hedging position and monitors the credit ratings of counterparties and does not anticipate losses due to counterparty nonperformance.  Management believes its use of derivative instruments to manage risk is in the Company’s best interest.  However, the Company’s use of derivative financial instruments may result in short-term gains or losses and increased earnings volatility.  The Company’s instruments are recorded in the consolidated balance sheets at fair value in other assets or other long-term liabilities.
 
Fair Value Measurements
 
Under ASC 825 (Financial Instruments), the Company is required to disclose the fair value of financial instruments for which it is practicable to estimate value.  The Company’s financial instruments consist of cash, accounts receivable, accounts payable, accrued liabilities, borrowings and an interest rate swap agreement.  IEC believes that recorded value approximates fair value for all cash, accounts receivable, accounts payable and accrued liabilities.
 


ASC 820 (Fair Value Measurements and Disclosures) defines fair value, establishes a framework for measurement, and prescribes related disclosures.  ASC 820 defines fair value as the price that would be received upon sale of an asset or would be paid to transfer a liability in an orderly transaction.  Inputs used to measure fair value are categorized under the following hierarchy:
 
Level 1: Quoted prices in active markets for identical assets or liabilities that the Company can access at the measurement date.
 
Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations in which all significant inputs are observable market data.
 
Level 3: Model-derived valuations in which one or more significant inputs are unobservable.
 
The Company deems a transfer between levels of the fair value hierarchy to have occurred at the beginning of the reporting period.  There were no such transfers during the first nine months of fiscal 20152016 or fiscal 2014.2015.
 
Revenue Recognition
 
The Company’s revenue is principally derived from the sale of electronic products built to customer specifications, but also from other value-added support services and repair work.  Revenue from product sales is recognized when (i) goods are shipped or title and risk of ownership have passed, (ii) the price to the buyer is fixed or determinable, and (iii) realization is reasonably assured. Service revenue is generally recognized once the service has been rendered.  For material management arrangements, revenue is generally recognized as services are rendered.  Under such arrangements, some or all of the following services may be provided: design, bid, procurement, testing, storage or other activities relating to materials the customer expects to incorporate into products that it manufactures.  Value-added support services revenue, including material management and repair work revenue, amounted to less than 5% of total revenue in each of the first nine months of fiscal 2015 or2016 and fiscal 2014.2015.
 
Provisions for discounts, allowances, rebates, estimated returns and other adjustments are recorded in the period the related sales are recognized.
 
Stock-Based Compensation
 
ASC 718 (Stock Compensation) requires that compensation expense be recognized for equity awards based on fair value as of the date of grant.  For stock options, the Company uses the Black-Scholes pricing model to estimate grant date fair value.  Costs associated with stock awards are recorded over requisite service periods, generally the vesting period.  If vesting is contingent

9



on the achievement of performance objectives, fair value is accrued over the period the objectives are expected to be achieved only if it is considered probable that the objectives will be achieved. 

The Company also has an employee stock purchase plan ("ESPP"(“ESPP”) that provides for a discounted stock purchase price. Compensation expense related to the discount is recognized as employees contribute to the plan. On May 21, 2013,During fiscal 2015 and the Compensation Committeefirst quarter of the Company’s Board of Directors suspended operation of the ESPP indefinitely in connection with the Prior Restatement further discussed below (including unavailability of the registration statement covering shares offered under the plan due to the failure of the Company to be current in its filings with the SEC until the Company filed its Form 10-K on December 24, 2013). Operation offiscal 2016, the ESPP was resumed effective October 1, 2014. On February 13, 2015, the Compensation Committee of the Company’s Board of Directors suspended operation of the ESPP indefinitely in connection with the 2014 Restatements described in Note 2—Restatement of Deferred Tax Asset Valuation Allowance and Excess and Obsolete Inventory Reserve (including unavailabilitybelow. The ESPP was reinstated as of the registration statement covering shares offered under the plan due to the failurebeginning of the Company to be current in its filings with the SEC).second quarter of fiscal 2016.

Restatement and Related Expenses
 
The Company restated its consolidated financial statements for the fiscal year ended September 30, 2012, and the interim fiscal quarters and year to date periods within the year ended September 30, 2012, included in the Company’s Annual Report on Form10-K/A and the fiscal quarter ended December 28, 2012, as reported in the Company’s Quarterly Report on Form 10-Q/A for that fiscal quarter (the "Prior Restatement"“Prior Restatement”).  The Company also restated its consolidated financial statements for the fiscal year ended September 30, 2014, and its interim financial statements for each quarterly period within the year ended September 30, 2014, included in the Company's Annual Report on Form 10-K/A, to correct an error in the valuation allowance on deferred income tax assets as well as an error in the estimate ofestimating excess and obsolete inventory reserves (the "2014 Restatements"“2014 Restatements”). The Prior Restatement and the 2014 Restatements together are referred to as the "Restatements"“Restatements”.

Restatement and related expenses representsrepresent third-party expenses arising from the Restatements. These expenses include legal and accounting fees incurred by the Company from external counsel and independent accountants directly attributable to the Restatements as well as other matters arising from the Prior Restatement including those more fully described in Note 17—Litigation.  The Company receives insurance reimbursement for certain of these expenses related to the Prior Restatement which may result in a benefit in a given period.



Legal Expense Accrual

The Company records legal expenses as they are incurred, based on invoices received or estimates provided by legal counsel. Future estimated legal expenses are not recorded until incurred.

Income Taxes and Deferred Taxes
 
ASC 740 (Income Taxes) requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns, but not in both.  Deferred tax assets are also established for tax benefits associated with tax loss and tax credit carryforwards.  Such deferred balances reflect tax rates that are scheduled to be in effect, based on currently enacted legislation, in the years the book/tax differences reverse and tax loss and tax credit carryforwards are expected to be realized.  An allowance is established for any deferred tax asset for which realization is not likely.
 
ASC 740 also prescribes the manner in which a company measures, recognizes, presents, and discloses in its financial statements uncertain tax positions that the Companya company has taken or expects to take on a tax return.  The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the position will be sustained following examination by taxing authorities, based on technical merits of the position.  The Company believes that it has no material uncertain tax positions.
 
Any interest or penalties incurred are reported as interest expense.  The Company’s income tax filings are subject to audit by various tax jurisdictions and current open years are fiscal 2010 through fiscal 2014.  The Company is currently under federal income tax audit for fiscal 2011 concluded in fiscal 2013 and diddoes not expect the audit to have a material impact on the financial statements.
 

10



Earnings Per Share
 
Basic earnings per common share are calculated by dividing income available to common stockholders by the weighted average number of shares outstanding during each period.  Diluted earnings per common share add to the denominator incremental shares resulting from the assumed exercise of all potentially dilutive stock options, as well as restricted (non-vested) stock, restricted stock units (“RSUs”) and anticipated issuance throughissuances under the employee stock purchase plan.  Options, and restricted stock and RSUs are primarily held by directors, officers and certain employees.  A summary of shares used in earnings per share (“EPS”) calculations follows.
 Three Months Ended Nine Months Ended Three Months Ended Nine Months Ended
Shares for EPS Calculation June 26,
2015
 June 27,
2014
 June 26,
2015
 June 27,
2014
 July 1,
2016
 June 26,
2015
 July 1,
2016
 June 26,
2015
                
Weighted average shares outstanding 10,199,431
 9,838,872
 10,049,395
 9,816,974
 10,211,347
 10,199,431
 10,210,805
 10,049,395
Incremental shares 
 
 
 
 
 
 
 
Diluted shares 10,199,431
 9,838,872
 10,049,395
 9,816,974
 10,211,347
 10,199,431
 10,210,805
 10,049,395

                
Anti-dilutive shares excluded 734,605
 504,738
 734,605
 504,738
 940,354
 734,605
 940,354
 734,605
 
As a result of the incremental shares being negative for the three and nine months ended July 1, 2016, the Company calculated diluted earnings per share using weighted average basic shares outstanding, as using diluted shares would be anti-dilutive.  As a result of the net loss for the three and nine months ended June 26, 2015, and June 27, 2014, the Company calculated diluted earnings per share using weighted average basic shares outstanding, as using diluted shares would be anti-dilutive to loss per share.

Dividends
IEC does not pay dividends on its common stock, as it is the Company’s current policy to retain earnings for use in the business.  Furthermore, the Company’s Fifth Amended and Restated Credit Facility Agreement with M&T Bank includes certain restrictions on paying cash dividends, as more fully described in Note 8—Credit Facilities. 

Use of Estimates
 
The preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”)GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, income and expenses and the disclosure of contingent assets and liabilities.  Actual results may differ from management’s estimates.
 


Statements of Cash Flows
 
The Company presents operating cash flows using the indirect method of reporting under which non-cash income and expense items are removed from net income. 
 
Recently Issued Accounting Standards
 
FASB ASU 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (a consensus of the FASB Emerging Issues Task Force),” was issued July 2013 and is effective for fiscal years beginning after December 15, 2013. ASU 2013-11 provides guidance on financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. This ASU applies to all entities with unrecognized tax benefits that also have tax loss or tax credit carryforwards in the same tax jurisdiction as of the reporting date. The Company adopted this ASU in the first quarter of fiscal 2015 and there was no impact upon adoption.
FASB ASUAccounting Standard Update (“ASU”) 2014-09, "Revenue“Revenue from Contracts with Customers,"Customers” was issued May 2014 and updates the principles for recognizing revenue.  The ASU will supersede most of the existing revenue recognition requirements in U.S. GAAP and will require entities to recognize revenue at an amount that reflects the consideration to which the Companya company expects to be entitled in exchange for transferring goods or services to a customer.  This ASU also amends the required disclosures of the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.  The guidance is effective for annual periods beginning after December 15, 2017, including interim periods within that period.  Early adoption is permitted for annual periods beginning after December 15, 2016.  The Company is determining its implementation approach and evaluating the potential impacts of the new standard on its existing revenue recognition policies and procedures.

FASB ASU 2016-08, “Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations” was issued in March 2016 and improves implementation guidance on principal versus agent considerations. The effective dates are the same as those for Topic 606.

FASB ASU 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing” was issued in April 2016 and adds further guidance on identifying performance obligations as well as improving licensing implementation guidance. The amendments do not change the core principle of the guidance in Topic 606. The effective dates are the same as those for Topic 606.

FASB ASU 2016-12, “Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients” was issued in June 2016 and clarifies the objective of the collectability criterion, presentation of taxes collected from customers, non-cash consideration, contract modifications at transition, completed contracts at transition and how guidance in Topic 606 is retrospectively applied. The amendments do not change the core principle of the guidance in Topic 606. The effective dates are the same as those for Topic 606.

FASB ASU 2014-12, "Compensation“Compensation - Stock Compensation (Topic 718), Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period,"Period” was issued June 2014. This guidance was issued to resolve diversity in accounting for performance targets. A performance target in a share-based payment that affects vesting and that could be achieved after the requisite service period should be accounted for as a performance condition and should not be reflected in the award’s grant date fair value. Compensation cost should be recognized over the required service period, if it is probable that the performance condition will be achieved. The guidance is

11



effective for annual periods beginning after December 15, 2015 and interim periods within those annual periods. The Company doesThis update did not anticipatehave a significant impact upon early adoption.

FASB ASU 2014-15, “Presentation of Financial Statements-Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” whichConcern” was issued September 2014. This provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued.  An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The ASU applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted. The Company does not anticipate a significant impact upon adoption.

FASB ASU 2015-03, “Interest - Imputation of Interest (Subtopic 835-30), Simplifying the Presentation of Debt Issuance Costs” was issued in April 2015. These amendments require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The ASU applies to all entities and is effective for public business entities for annual periods endingbeginning after December 15, 2015, and interim periods thereafter, with early adoption permitted. The guidance should be applied on a retrospective basis. The Company does not anticipate a significant impact upon adoption.

FASB ASU 2015-11, "Simplifying“Simplifying the Measurement of Inventory"Inventory” was issued onin July 22, 2015. This requires entities to measure most inventory “at the lower of cost and net realizable value,” thereby simplifying the current guidance under which an entity must measure inventory at the lower of cost or market. The ASU will not apply to inventories that are measured by using either the last-in, first-outfirst-hout method or the retail inventory method. For public business entities, the ASU is effective prospectively for


annual periods beginning after December 15, 2016, and interim periods therein. Upon transition, entities must disclose the nature of and reason for the accounting change. The Company does not anticipate a significant impact upon adoption.
FASB ASU No. 2015-15, Interest—Imputation of Interest: Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements” was issued in August 2015 which permits an entity to report deferred debt issuance costs associated with a line-of-credit arrangement as an asset and to amortize such costs over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings under the credit line. The ASU applies to all entities and is effective for public business entities for annual periods beginning after December 15, 2015, and interim periods thereafter, with early adoption permitted. The guidance should be applied on a retrospective basis. The Company does not anticipate a significant impact upon adoption.

FASB ASU 2015-17, “Income Taxes Balance Sheet Classification of Deferred Taxes” was issued in November 2015. This requires entities to classify deferred tax liabilities and assets as noncurrent in a classified statement of financial position and applies to all entities that present a classified statement of financial position. For public entities, this update is effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company does not anticipate a significant impact upon adoption.
FASB ASU 2016-09, “Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting” was issued in March 2016. This simplifies accounting for several aspects of share-based payment including income tax consequences, classification of awards as either equity or liability and classification on the statement of cash flows. For public entities, this update is effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company does not anticipate a significant impact upon adoption.
FASB ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326)” was issued in June 2016.  This ASU amends the Board’s guidance on the impairment of financial instruments. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses, which the FASB believes will result in more timely recognition of such losses. This ASU is effective for fiscal years beginning after December 15, 2019. Early adoption will be permitted.  The Company does not anticipate a significant impact upon adoption.

NOTE 2—RESTATEMENT OF DEFERRED TAX ASSET VALUATION ALLOWANCESCB DIVESTITURE AND EXCESS AND OBSOLETE INVENTORY RESERVEDISCONTINUED OPERATIONS

As previously disclosed, SCB, a wholly owned subsidiary of the Company, entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”), effective as of July 9, 2015, by and between SCB and DCX-Chol Enterprises, Inc. (“DCX”), whereby DCX purchased the multi-conductor stranded copper cable and harness assemblies manufacturing and servicing business previously operated by SCB. DCX, a provider of engineered high performance interconnect products, purchased substantially all assets and assumed certain obligations and liabilities of SCB for the agreed upon selling price of $2.5 million, adjusted to $2.4 million due to certain deposits and prorations. DCX paid the adjusted purchase price in cash at closing. The Asset Purchase Agreement contains indemnification provisions of each party with respect to breaches of representations, warranties and covenants and certain other specified matters. Prior to this transaction, there were no material relationships between the Company and DCX or between DCX and any officer, director or affiliate of the Company.

During the third quarter of fiscal 2015, the Company received an offer from DCX to purchase substantially all the assets and assume certain liabilities of SCB for approximately $2.5 million. The Company's willingness to accept the offer was considered to be an indication of fair value and as such, impairment charges of $4.1 million were taken to adjust SCB's assets to fair value as of June 26, 2015.



The Consolidated Balance Sheet at September 30, 2014 and Consolidated Statementspre-tax loss on the sale of Income, Changes in Stockholders’ Equity and Cash FlowsSCB for the year then ended September 30, 2015 included in Loss on discontinued operations, net in the income statement was calculated as follows:
  July 9, 2015
(in thousands) (unaudited)
Purchase price $2,405
Net book value of assets sold (2,630)
Legal fees associated with closing (114)
Finder's fee (50)
Sales tax on asset sale (20)
Other (24)
Loss on sale of SCB $(433)

Carrying amounts of major classes of assets and the fiscal quarters ended December 27, 2013, March 28, 2014liabilities that were disposed of follows:
  July 9, 2015
(in thousands) (unaudited)
Inventories, net $1,803
Other current assets 53
Fixed assets, net 916
Intangible assets, net 
Customer deposits (142)
Net assets sold $2,630

SCB's revenue and June 27, 2014 have been restated.loss before income taxes follows:
  Three Months Ended Nine Months Ended
  June 26,
2015
 June 26,
2015
(in thousands)    
Net sales $1,867
 $5,287
Loss before income taxes $(4,392) $(5,745)

The summary impacts of the restatement adjustmentsloss on the Company’s previously reported consolidated net lossdiscontinued operations for the three and nine months ended June 27, 2014 follows:
  Three Months Ended Nine Months Ended
  June 27,
2014
 June 27,
2014
(in thousands)    
Net income/(loss) - Previously reported $22
 $(1,646)
Deferred tax asset valuation allowance adjustment 3
 (14,016)
Excess and obsolete inventory reserve adjustment (85) (443)
Net income/(loss) - Restated $(60) $(16,105)
The impacts26, 2015 was comprised of the restatement adjustments on the Company’s previously reported consolidated income statement for the three and nine months ended June 27, 2014 follows:

12



  Three Months Ended Nine Months Ended
  June 27, 2014 June 27, 2014
   As Reported  Adjustment  Restated  As Reported  Adjustment  Restated
(in thousands, except per share data)          
Cost of sales $29,112
 $85
 $29,197
 $87,675
 $443
 $88,118
Gross profit 3,880
 (85) 3,795
 12,259
 (443) 11,816
Operating profit /(loss) 583
 (85) 498
 (1,195) (443) (1,638)
Income/(loss) before income
taxes
 25
 (85) (60) (2,623) (443) (3,066)
Provision for /(benefit from)
income taxes
 3
 (3) 
 (977) 14,016
 13,039
Net income /(loss) 22
 (82) (60) (1,646) (14,459) (16,105)
Net income /(loss) per share $
 $(0.01) $(0.01) $(0.17) $(1.47) $(1.64)

While closing the first quarter of fiscal 2015, the Company revisited its assessment of realizability of deferred tax assets and identified an error in interpretation of the guidance for the valuation allowance on deferred tax assets.

The Company performed a realizability assessment for the fourth quarter of fiscal 2014 and came to the conclusion thatoperating losses; there was no additional valuation allowance required on federal deferred tax assets; however, due to a change in New York State tax laws which reduces the State tax rateprovision or benefit from taxes for qualified manufacturers to 0% for IEC's fiscal year ended September 30, 2015, the valuation allowance was increased by $1.1 million to fully reserve for New York State deferred tax assets.these periods.

This conclusion regarding federal deferred tax assets at the time of the fourth quarter of fiscal 2014 assessment was based on the Company's evaluation of the negative and positive evidence available at that time. The Company's cumulative loss in recent years was considered; however, the Company determined that the goodwill and intangibles impairment charge taken in the fourth quarter of fiscal 2013 should be excluded when weighing the evidence. Positive evidence included taxable income each year beginning in 2004 through 2013, forecasted results and backlog. At the time of our Original 2014 Form 10-K filing, there was forecasted pre-tax income for fiscal 2015 and earnings growth was forecasted in subsequent years. The Company's Federal net operating losses ("NOLs") do not begin to expire until 2022. As aggregate future taxable income was expected to exceed Federal NOLs, it was concluded that realizability of these was more likely than not. In addition, future taxable income was expected to exceed the amount of Federal NOLs and deferred tax assets expected to reverse in future years combined. As such, there was no additional valuation allowance recorded for federal deferred tax assets.

During the process of closing the first quarter of fiscal 2015, the Company revisited its determination regarding the valuation of its deferred tax assets. After consulting applicable accounting guidance and interpretations thereof, the Company determined that the impairment charge should not have been excluded from the cumulative loss calculation. Once a cumulative three year loss is identified, it is very difficult to overcome this negative evidence. IEC did not believe there was enough positive evidence to outweigh the cumulative three year loss. Based on this interpretation, the Company recorded a full valuation allowance beginning in the second quarter of fiscal 2014, which is when the Company first accumulated a three year loss. As such, an error in the valuation allowance on deferred income tax assets was identified resulting in an understatement of tax expense and overstatement of deferred tax assets. The Company determined this error was material and required restatement of its consolidated financial statements for fiscal 2014 as well as the second, third and fourth quarters of fiscal 2014.

The Company also performed additional analysis related to its excess and obsolete inventory reserves. This analysis identified an error in the Albuquerque and SCB operating locations. The Company discovered that not all pertinent information was factored into the excess and obsolete inventory reserve estimates during fiscal 2014.

During fiscal 2014, given the time that had passed since SCB was acquired in December 2010, the Company should have factored in the age of SCB's inventory and its demand when estimating its excess and obsolete inventory reserve. Instead, the Company employed an approach that factored in the usage of the inventory since the SCB acquisition date and estimated a general reserve for remaining inventory. The restated excess and obsolete inventory reserve for SCB is based on an analysis that appropriately incorporates the age of SCB's inventory and its demand and involves the review of specific inventory items with a large extended value. This additional analysis was performed consistently for all items, regardless of whether they were purchased before or after the date the Company acquired SCB.

The Albuquerque excess and obsolete inventory reserve as originally reported did not take into consideration facts and circumstances related to certain customer programs. The Company's methodology was applied consistently, however, the rigor

13



around the analysis of excess inventory did not take into account certain customer information that was available at the time. As a result, the Company concluded the inventory on hand for these customer programs was not adequately reserved for.

NOTE 3—ALLOWANCE FOR DOUBTFUL ACCOUNTS

A summary follows of activity in the allowance for doubtful accounts during the nine months ended July 1, 2016 and June 26, 2015 and June 27, 2014.
2015. 
 Nine Months Ended Nine Months Ended
Allowance for Doubtful Accounts June 26,
2015
 June 27,
2014
 July 1,
2016
 June 26,
2015
(in thousands)        
Allowance, beginning of period $525
 $452
 $423
 $525
Provision for doubtful accounts (23) 257
 253
 (23)
Write-offs (64) (37) (298) (64)
Allowance, end of period $438
 $672
 $378
 $438
 


NOTE 4—INVENTORIES  

A summary of inventory by category at period end follows:
 
Inventories
June 26,
2015

September 30,
2014

July 1,
2016

September 30,
2015
(in thousands)
 

(restated)
 


Raw materials
$21,147

$16,769

$12,705

$17,637
Work-in-process
8,163

7,906

5,855

8,512
Finished goods
2,149

757

3,256

1,341
Total inventories
31,459

25,432

21,816

27,490
Reserve for excess/obsolete inventory
(4,025)
(2,906)
(1,703)
(1,737)
Inventories, net
$27,434

$22,526

$20,113

$25,753

The Company has restated its excess and obsolete inventory reserve for the fiscal year ended September 30, 2014 and interim quarterly periods during the fiscal year then ended. The restatement is further discussed in Note 2—Restatement of Deferred Tax Asset Valuation Allowance and Excess and Obsolete Inventory Reserve.

NOTE 5—FIXED ASSETS  

A summary of fixed assets and accumulated depreciation at period end follows:
Fixed Assets June 26,
2015
 September 30,
2014
 July 1,
2016
 September 30,
2015
(in thousands)        
Land and improvements $1,601
 $1,601
 $1,601
 $1,601
Buildings and improvements 14,008
 13,452
 14,199
 14,161
Leasehold improvements 1,487
 1,458
Machinery and equipment 27,967
 26,996
 26,341
 26,061
Furniture and fixtures 7,571
 7,207
 7,349
 7,291
Construction in progress 952
 381
 2,807
 1,028
Total fixed assets, at cost 53,586
 51,095
 52,297
 50,142
Accumulated depreciation (36,534) (33,245) (37,066) (34,699)
Accumulated impairment - building and improvements $(96) $
Fixed assets, net $16,956
 $17,850
 $15,231
 $15,443
 

14



Depreciation expense during the three and nine months ended July 1, 2016 and June 26, 2015 and June 27, 2014 follows:
 Three Months Ended Nine Months Ended Three Months Ended Nine Months Ended
 June 26,
2015
 June 27,
2014
 June 26,
2015
 June 27,
2014
 July 1,
2016
 June 26,
2015
 July 1,
2016
 June 26,
2015
(in thousands)                
Depreciation expense $1,049
 $1,141
 $3,289
 $3,406
 $717
 $926
 $2,364
 $2,910

During the third quarter of fiscal 2015, the Company received an offer to purchase substantially all the assets and assume certain liabilities of the SCB reporting unit for approximately $2.5 million. At June 26, 2015, the Company was actively considering options regarding SCB which included rehabilitating, selling or shutting down operations. The Company's SCB assets did not meet the criteria to be deemed held for sale as of the end of the third quarter as there was not an approved plan to sell such assets. However, the willingness to accept the offer is considered to be an indication of fair value and as such, an impairment charge of $0.1 million was taken to adjust the reporting unit's fixed assets to fair value. Further information regarding the agreement to sell certain assets and liabilities of the SCB reporting unit (the "Asset Purchase Agreement") is disclosed in Note 19—Subsequent Events.

NOTE 6—INTANGIBLE ASSETS  

IEC's intangible assets (other than goodwill) were acquired in connection with purchasespurchase of SCB in the first quarter of fiscal 2011 and Albuquerque in fiscal 2010.
 
Among SCB’s key attributes as an acquisition candidate were the relationships established with a number of military and defense contractors.  The anticipated profitability of those relationships was considered by IEC in arriving at an amount to offer for SCB and also became the basis for allocating a portion of the purchase price to a related customer relationship intangible asset.  Based upon several key assumptions and a detailed analysis of value, $5.9 million was allocated to this intangible asset.  The asset was being amortized over its 15-year estimated useful life, using the straight-line method.
The Company recorded an impairment of the customer relationship intangible asset of $2.4 million in the fourth quarter of fiscal 2013 and a further impairment charge of $2.0 million in the third quarter of fiscal 2015. 
In connection with the SCB acquisition, IEC also allocated $100 thousand to an intangible asset representing the estimated value of a five-year, non-compete agreement entered into with SCB’s selling shareholders.  This intangible asset was being amortized evenly over its contractual life, however the remaining balance was impaired in the third quarter of fiscal 2015.

During the third quarter of fiscal 2015, the Company received an offer to purchase substantially all the assets and assume certain liabilities of SCB for approximately $2.5 million. At June 26, 2015, the Company was actively considering options regarding SCB which included rehabilitating, selling or shutting down operations. The Company's SCB assets did not meet the criteria to be deemed held for sale as of the end of the third quarter as there was not an approved plan to sell such assets. However, the Company's willingness to accept the offer is considered to be an indication of fair value and as such, impairment charges were taken to adjust SCB's assets to fair value. Further information regarding the agreement to sell certain assets and liabilities of SCB (the "Asset Purchase Agreement") is disclosed in Note 19—Subsequent Events.
As for Albuquerque, itsAlbuquerque's building and land were acquired subject to an Industrial Revenue Bond (“IRB”) that exempts the property from real estate taxes for the term of the IRB.  The tax abatement was valued at $360 thousand at the date of acquisition, and such value is being amortized over the 9.2 year exemption period that remained as of the acquisition date.  No impairment has been taken for this asset since the Albuquerque acquisition.
 

15




A summary of intangible assets by category and accumulated amortization at period end follows:
 
Intangible Assets
June 26,
2015

September 30,
2014

July 1,
2016

September 30,
2015
(in thousands)











Customer relationships - SCB
$5,900

$5,900
Property tax abatement - Albuquerque
360

360

360

360
Non-compete agreement - SCB
100

100
Total intangibles
6,360

6,360
Accumulated amortization (1,747) (1,556) (255) (226)
Accumulated impairment - customer relationships (4,460) (2,412)
Accumulated impairment - Non-compete agreement (9) 
Intangible assets, net $144
 $2,392
 $105
 $134

Amortization expense during the three and nine months ended July 1, 2016 and June 26, 2015 and June 27, 2014 follows:
 
 Three Months Ended Nine Months Ended Three Months Ended Nine Months Ended
Amortization Expense June 26,
2015
 June 27,
2014
 June 26,
2015
 June 27,
2014
 July 1,
2016
 June 26,
2015
 July 1,
2016
 June 26,
2015
(in thousands)                
Intangible amortization expense $64
 $64
 $191
 $191
 $10
 $10
 $29
 $29
 
A summary of amortization expense for the next five years follows:
Future Amortization Estimated future amortization Estimated future amortization
(in thousands) 

 

Twelve months ended March, 

2016 $39
Twelve months ended June, 

2017 39
 $39
2018 39
 39
2019 27
 27
2020 
2021 and thereafter 
2020 and thereafter 
 
NOTE 7—GOODWILL  

Goodwill balances resultingThe goodwill balance of $0.1 million resulted from the acquisitionsacquisition of SCB in the first quarter of fiscal 2011 and Celmet in fiscal 2010 were $13.7 million and $0.1 million, respectively, prior to the impairments described below.
Since its acquisition, SCB has operated as a reporting unit of the Company, primarily in the aerospace & defense (previously disclosed as military & aerospace) market sector.  As previously disclosed, due to changing circumstances, the Company determined it was necessary to perform a quantitative assessment which resulted in a goodwill impairment charge of $11.8 million recorded in the fourth quarter of fiscal 2013.
A further impairment charge of $1.9 million was recorded in the third quarter of fiscal 2015 to reduce the value of the goodwill to zero. During the third quarter of fiscal 2015, the Company received an offer to purchase substantially all the assets and assume certain liabilities of SCB for approximately $2.5 million. At June 26, 2015, the Company was actively considering options regarding SCB which included rehabilitating, selling or shutting down operations. The Company's SCB assets did not meet the criteria to be deemed held for sale as of the end of the third quarter as there was not an approved plan to sell such assets. However, the Company's willingness to accept the offer is considered to be an indication of fair value and as such, impairment charges were taken to adjust SCB's assets to fair value. Further information regarding the Asset Purchase Agreement is disclosed in Note 19—Subsequent Events.
As for the goodwill from the Celmet acquisition, there2010. There has been no impairment for this goodwill since the acquisition date.
 

16




A summary of the total goodwill and accumulated impairment at period end follows:
Goodwill
June 26,
2015
 September 30,
2014
(in thousands)
 
  
Goodwill
$13,810
 $13,810
Accumulated impairment
(13,709) (11,805)
Goodwill, net
$101
 $2,005
NOTE 8—CREDIT FACILITIES  

A summary of borrowings at period end follows:   
 Fixed/ June 26, 2015 September 30, 2014 Fixed/ July 1, 2016 September 30, 2015
 Variable   Interest   Interest Variable   Interest   Interest
Debt Rate Maturity Date Balance Rate (1) Balance Rate (1) Rate Maturity Date Balance 
Rate (1)
 Balance 
Rate (1)
(in thousands)            
($ in thousands)            
M&T credit facilities:                
Revolving Credit Facility v 1/18/2016 $11,240
 4.44% $7,431
 4.44% v 1/18/2018 $5,216
 4.75% $12,415
 4.50%
Term Loan A f 2/1/2022 7,315
 3.98
 8,148
 3.98
 f 2/1/2020 3,878
 3.98
 4,804
 3.98
Term Loan B v 2/1/2023 10,733
 3.43
 11,783
 3.41
 v 2/1/2023 9,217
 3.71
 10,383
 3.45
Albuquerque Mortgage Loan v 2/1/2018 2,533
 4.69
 2,733
 4.69
 v 2/1/2018 2,244
 5.00
 2,467
 4.75
Celmet Building Term Loan f 11/7/2018 1,094
 4.72
 1,192
 4.72
 f 11/7/2018 953
 4.72
 1,062
 4.72
                
Other credit facilities:                
Albuquerque Industrial Revenue Bond f 3/1/2019 100
 5.63
 100
 5.63
 f 3/1/2019 100
 5.63
 100
 5.63
                
Total debt 33,015
   31,387
   21,608
   31,231
  
Less: current portion (14,148)   (2,908)   (2,665)   (2,908)  
Long-term debt $18,867
   $28,479
   $18,943
   $28,323
  
 
(1) Rates noted are before impact of interest rate swap.
 
M&T Bank Credit Facilities
 
On January 18, 2013,December 14, 2015, the Company and M&T Bank entered into the Fifth Amended and Restated Credit Facility Agreement (“Fifth Amended Credit Agreement”), which amends and restates in its entirety the Fourth Amended and Restated Credit Facility Agreement (“dated as of January 18, 2013, as amended (the “2013 Credit Agreement”), replacing a prior agreement dated December 17, 2010. Variable rate debt under the 2013 Credit Agreement accrues interest at Libor plus the applicable marginal interest rate that fluctuates based on the Company's Debt to EBITDARS Ratio, as defined below.. Borrowings under the 2013Fifth Amended Credit Agreement are secured by, among other things, the assets of IEC and its subsidiaries. The 2013Fifth Amended Credit Agreement as amended prohibits the Company from paying dividends or repurchasing or redeeming its common stock without first obtaining the consent of M&T Bank.

Except as described below, the terms, conditions, covenants, guarantees and collateral previously in effect under the 2013 Credit Agreement will continue substantially unchanged under the Fifth Amended Credit Agreement. Before entering into the Fifth Amended Credit Agreement, the Company and M&T Bank were performing under the terms of the Sixth Amendment to the 2013 Credit Agreement entered into on May 8, 2015 (the “Sixth Amendment”).

Individual debt facilities provided under the Fifth Amended Credit Agreement, which remain mostly unchanged from the 2013 Credit Agreement, as amended by the first two amendments, both of which occurred prior to fiscal 2014, are described below:

a)
Revolving Credit Facility (“Revolver”): Up to $20 million is available through January 18, 2016.2018. The maximum amount the Company may borrow is determined based on a borrowing base calculation as defined in the 2013 Credit Agreement as described below.
b)
Term Loan A: $10.0 million was borrowed on January 18, 2013. Principal is being repaid in 108 equal monthly installments of $93 thousand.
c)
Term Loan B: $14.0 million was borrowed on January 18, 2013. Principal is being repaid in 120 equal monthly installments of $117 thousand.

17



d)
Albuquerque Mortgage Loan: $4.0 million was borrowed on December 16, 2009. The loan is secured by real property in Albuquerque, NM, and principal is being repaid in equal monthly installments of $22 thousand plus a balloon payment of $1.8 million due at maturity.
e)
Celmet Building Term Loan: $1.3 million was borrowed on November 8, 2013 pursuant to an amendment to the 2013 Credit Agreement. The proceeds were used to reimburse the Company’s cost of purchasing theits Rochester, New York facility. Principal is being repaid in 59 equal monthly installments of $11 thousand plus a balloon payment due at maturity. 



Borrowing Base

TheUnder the Fifth Amended Credit Agreement, the maximum amount the Company maycan borrow under the Revolver is the lesser of (i) 85% of eligible receivables plus 35% of eligible inventories (up to a cap of $3.75 million) or (ii) $20$20.0 million. AtThe Sixth Amendment removed the Company's election,provision from the 2013 Credit Agreement, that allowed the Company to elect that another 35% of eligible inventories may be included in the borrowing base for limited periods of time during which a higher rate of interest iswas charged on the Revolver. Borrowings based on inventory balances are furtherwere limited to a cap of $3.75 million, or when subject to the higher percentage limit, $4.75 million.
The Sixth Amendment also removed the provision in the 2013 Credit Agreement that allowed for borrowing at an increased interest rate margin based on 85% of eligible accountsreceivables plus 70% of eligible inventories up to a maximum of $4.75 million.

At June 26,July 1, 2016 and September 30, 2015, the upper limit on Revolver borrowings was $19.5 million.$17.7 million and $20.0 million, respectively. Average available balances on the Revolver amounted to $9.9 million and $10.8$9.7 million during the nine months ended June 26, 2015 and June 27, 2014, respectively.July 1, 2016.

Interest Rates

ForUnder the Fifth Amended Credit Agreement, variable rate debt accrues interest at LIBOR plus the applicable marginal interest rate that fluctuates based on the Company's Debt to EBITDAS Ratio, as defined below. Under the Fifth Amended Credit Agreement the applicable marginal interest rate was fixed on December 14, 2015 as follows: 4.25% for the Revolver, 4.50% for the Albuquerque Mortgage Loan and 3.25% for the Term Loan B, until the tenth day following the date the Company delivered its quarterly covenant calculation for the first quarter of fiscal 2016.  Subsequent to this date, for the variable rate debt, the interest rate is LiborLIBOR plus the applicable margin interest rate that is based on the Company's Debt to EBITDARS Ratio, as defined below.EBITDAS Ratio. Changes to applicable margins and unused fees resulting from the Debt to EBITDARSEBITDAS Ratio generally become effective mid-way through the subsequent quarter. The Second Amendment to the 2013 Credit Agreement entered into on August 6, 2013 (the "Second Amendment") modified the ranges of applicable margins and unused fees by increasing bothbased on the lower and upper limit of each range with respect to the applicable debt facility.

The higher Debt to EBITDARS Ratio calculatedsecond quarter covenant calculations were as of June 28, 2013, in conjunction with the Second Amendment resulted in an increase of 0.25% in the effective rate applicable to Term Loan B and Albuquerque Mortgage Loan and the unused commitment feefollows: 4.25% for the Revolver, remained unchanged.

The Fourth Amendment to the 2013 Credit Agreement (the "Fourth Amendment") fixed the applicable margin for the Revolver at 4.25%,4.50% for the Albuquerque Mortgage Loan at 4.50% and 3.25% for the Term Loan B at 3.25% and the unused fee at 0.50%, in each case for the periodB.

Prior to December 13, 2013 through December 13, 2014 and if the Company was not compliant with financial covenants on December 13, 2014, during the period of non-compliance. The Fifth Amendment further fixed the applicable margins at the rates noted in the Fourth Amendment through March 27,14, 2015, and if the Company was not compliant with financial covenants on March 27, 2015, during the period of non-compliance. Additionally, the Sixth Amendment to the 2013 Credit Agreement entered into on May 8, 2015 (the "Sixth Amendment") further fixed each facility’s applicable margin at the rates established under the Fourth and Fifth Amendments through March 31, 2016 as follows: 4.25% for the Revolver, 4.50% for the Albuquerque Mortgage Loan and thereafter if3.25% for the Company is not then in compliance with its financial covenants.Term Loan B. The applicable unused line fee of 0.50% also was extended through March 31, 2016, and thereafter if the Company is not in compliance with its financial covenants.

The Company incurs quarterly unused commitment fees ranging from 0.125%0.250% to 0.500% of the excess of $20.0 million over average borrowings under the Revolver. Fees incurred amounted to $38.2$44.9 thousand and $40.5$38.2 thousand during the nine months ended July 1, 2016 and June 26, 2015, and June 27, 2014, respectively. The fee percentage varies based on the Company's Debt to EBITDARS Ratio, as defined below.EBITDAS Ratio.

Interest Rate Swap

In connection with the 2013 Credit Agreement, on January 18, 2013, the Company and M&T Bank entered into an interest rate swap arrangement (“Swap Transaction”). The Swap Transaction is for a notional amount of $14.0 million with an effective date of February 1, 2013 and a termination date of February 1, 2023. The Swap Transaction is designed to reduce the variability of future interest payments with respect to Term Loan B by effectively fixing the annual interest rate payable on the loan’s outstanding principal. Pursuant to the Swap Transaction, the Company’s one month LiborLIBOR rate is swapped for a fixed rate of 1.32%. When the swap fixed rate is added to the Term Loan B spread of 2.50%3.25%, the Company’s interest rate applicable to Term Loan B is effectively fixed at 3.82%. The Fourth Amendment and Fifth Amendment temporarily modified the Term Loan B spread to 3.25% which results in an effectively fixed rate of 4.57%.


18



Financial Covenants

The 2013Fifth Amended Credit Agreement also contains various affirmative and negative covenants including financial covenants. The Company is required to maintain (i) a minimum level of quarterly EBITDARS ("EBITDAS, as defined below (“Quarterly EBITDARS"EBITDAS”), (ii) a ratio of total debt to twelve month EBITDARSEBITDAS (“Debt to EBITDARSEBITDAS Ratio”) that is below a specified limit, and (iii) a minimum fixed charge coverage ratio (“Fixed Charge Coverage Ratio”), (iv) a maximum level of inventory (“Maximum Inventory”), and (v) a maximum amount of capital expenditures (“Maximum Capital Expenditures”). The Debt to EBITDARSEBITDAS Ratio is the ratio of debt to earnings before interest, taxes, depreciation, amortization rent expense and non-cash stock compensation expense.expense (“EBITDAS”). The Fixed Charge Coverage Ratio compares (i) 12 month EBITDA plus non-cash stock compensation expense minus unfinanced capital expenditures minus cash taxes paid, to (ii) the sum of interest expense, principal payments sale-leaseback payments and dividends, if any (fixed charges). The Maximum Inventory covenant allows for specific levels of inventory as defined by the agreement. The Maximum Capital Expenditures covenants allow for a maximum amount of capital expenditures on an annual basis.



On May 15, 2013 we obtained an amendmentJune 20, 2016, the Company and M&T entered into a First Amendment to the 2013Fifth Amended and Restated Credit Facility Agreement (the “First Amendment”), which modifiedamended the DebtFifth Amended Credit Facility. The First Amendment increased the Maximum Capital Expenditures, as defined in the Credit Agreement, covenant from $3.5 million to EBITDARS Ratio and Fixed Charge Coverage Ratio covenants. The Second Amendment, obtained on August 6, 2013 modified the Debt to EBITDARS Ratio. On December 13, 2013 we obtained the Fourth Amendment and on February 4, 2014 we obtained a further amendment$4.5 million annually.

Covenant Ratios in effect at July 1, 2016, pursuant to the 2013Fifth Amended Credit Agreement, (the “Fifth Amendment”) which further modifiedas amended by the ratios.First Amendment, are as follows:
The Second Amendment also amended two definitions used in
Debt to EBITDAS Ratio:  
6/26/15 through and including 9/30/15 < 5.75 to 1.00
10/01/15 through and including 1/01/16 < 5.10 to 1.00
1/02/16 through and including 4/01/16 < 3.95 to 1.00
4/02/16 through and including 7/01/16 < 3.65 to 1.00
7/02/16 through and including 9/30/16 < 3.10 to 1.00
Thereafter < 3.10 to 1.00
   
Minimum Quarterly EBITDAS :  
Fiscal Quarter ending 9/30/15 $1,500,000
Fiscal Quarter ending 1/01/16 1,785,000
Fiscal Quarter ending 4/01/16 1,900,000
Fiscal Quarter ending 7/01/16 1,800,000
Fiscal Quarter ending 9/30/16 2,190,000
Thereafter 2,190,000
   
Fixed Charge Coverage Ratio:  
6/26/15 through and including 9/30/15 > 0.45 to 1.00
10/01/15 through and including 1/01/16
 > 0.75 to 1.00
1/02/16 through and including 4/01/16
 > 1.00 to 1.00
4/02/16 through and including 7/01/16
 > 1.10 to 1.00
7/2/16 and thereafter > 1.25 to 1.00
   
Maximum Inventory:  
As of January 1, 2016 $30,000,000
As of April 1, 2016 29,000,000
As of July 1, 2016 28,000,000
As of September 30, 2016 27,000,000
As of December 30, 2016 26,000,000
As of the end of the Fiscal Quarter ending March 31, 2017 25,000,000
As of the end of each Fiscal Quarter thereafter 25,000,000
   
Maximum Capital Expenditures $4,500,000

Prior to the calculation of the financial covenants, including: (i) the definition of net income, to add back, through the fiscal quarter ending June 27, 2014, up to $1.1 million of legal and accounting fees associated with the restatement, and (ii) the definition of interest expense as related to Rate Management Transactions (defined in the 2013Fifth Amended Credit Agreement), to be “the net cash cost or benefit associated with Rate Management Transactions net cash benefit or loss”.
PursuantAgreement, pursuant to the Sixth Amendment, M&T Bank agreed to (i) modify the financial covenants related to Quarterly EBITDARS, the Debt to EBITDARS Ratio and the Fixed Coverage Charge Ratio and (ii) waive events of default arising from the Company’s non-compliance with these covenants during the fiscal quarters ended December 26, 2014 and March 27, 2015. Quarterly EBITDARS was the quarterly measurement of earnings before interest, taxes, depreciation, amortization, rent expense and non-cash stock compensation expense. The Debt to EBITDARS Ratio was the ratio of debt to earnings before interest, taxes, depreciation, amortization, rent expense and non-cash stock compensation expense. The Fixed Charge Coverage Ratio compared (i) 12 month EBITDA plus non-cash stock compensation expense minus unfinanced capital expenditures minus cash taxes paid, to (ii) the sum of interest expense, principal payments, sale-leaseback payments and dividends, if any (fixed charges). The Sixth Amendment also amended the definition of EBITDARS under the 2013 Credit Agreement to add back a maximum amount of professional services fees and expenses incurred and paid or to be paid prior to September 30, 2015. EBITDARS as amended and restated means,meant, for the applicable period, earnings before interest, taxes, depreciation, amortization, plus (i) payments due under the M&T sale-leaseback arrangement, (ii) non-cash


stock option expense and (iii) professional services fees and expenses incurred and paid or to be paid prior to September 30, 2015, up to a maximum of (a) for the fiscal quarter ended December 26, 2014, $235,112, (b) for the fiscal quarter ending March 27, 2015, $2,652,659, (c) for the fiscal quarter ending June 26, 2015, $200,000 plus costs incurred and paid by Borrowerthe Company during such Fiscal Quarterfiscal quarter in connection with mortgages, environmental site assessments, title insurance and appraisals ("Costs") and (d) for the fiscal quarter ending September 30, 2015, $200,000 plus costs incurred and paid by Borrowerthe Company during such Fiscal Quarter,fiscal quarter, all on a consolidated basis and determined in accordance with GAAP on a consistent basis.

Covenant Ratios in effect at June 26, 2015, after the 6th Amendment, are as follows:
ŸDebt to EBITDARS Ratio:
2013 Credit Agreement, after Sixth Amendment:
3/28/15 through and including 6/26/15
< 5.75 to 1.00
6/27/15 through and including 9/30/15
< 5.75 to 1.00
10/1/15 through and including 12/25/15
< 5.50 to 1.00
12/26/15 through and including 3/25/16
< 5.00 to 1.00
3/26/16 through and including 6/24/16
< 4.50 to 1.00
6/25/16 through and including 9/30/16
< 4.00 to 1.00
10/1/16 and thereafter< 3.50 to 1.00
ŸFixed Charge Coverage Ratio:
2013 Credit Agreement, after Sixth Amendment:
3/28/15 through and including 6/26/15
> 0.60 to 1.00
6/27/15 through and including 9/30/15
> 0.45 to 1.00
10/1/15 through and including 12/25/15
> 0.75 to 1.00
12/26/15 through and including 3/25/16
> 1.00 to 1.00
3/26/16 through and including 6/24/16
> 1.10 to 1.00
6//25/16 and thereafter
> 1.25 to 1.00


19



The Sixth Amendment also modified the Quarterly EBITDARS covenant to be equal to or greater than $1.25 million for the fiscal quarter ending June 26, 2015, and $1.5 million for each fiscal quarter thereafter.

A summary of financial covenant compliance follows:

  Quarterly EBITDARSEBITDAS Debt to EBITDARSEBITDAS Ratio Fixed Charge Coverage RatioMaximum InventoryMaximum Capital Expenditures
Fiscal Quarters      
Third 20152016 Compliant Compliant CompliantCompliantMeasured Annually
Second 20152016 WaivedCompliant WaivedCompliant WaivedCompliantCompliantMeasured Annually
First 20152016 WaivedCompliant WaivedCompliant WaivedCompliantCompliantMeasured Annually
       
Fourth 20142015CompliantCompliant Compliant Not MeasuredApplicable Not MeasuredApplicable
Third 20142015 (1)
CompliantCompliant Compliant Not MeasuredApplicable Not MeasuredApplicable
Second 20142015 (1)
WaivedWaived Waived Not MeasuredApplicable Not MeasuredApplicable
First 20142015 (1)
WaivedWaived Waived Not MeasuredApplicable Not MeasuredApplicable

(1) The Company was subject to the 2013 Credit Agreement during these periods.

As a result of the 2014 Restatements as described in Note 2—Restatement1—Our Business and Summary of Deferred Tax Asset Valuation Allowance and Excess and Obsolete Inventory Reserve,Significant Accounting Policies, the Company was in default of the Credit Agreement for failure to deliver financial statements prepared in accordance with GAAP.GAAP for each of the quarters of fiscal 2014 and the fiscal quarter ending December 26, 2014. The Company received a waiver from M&T regarding this event of default.

Other Borrowings

a)
Albuquerque Industrial Revenue Bond: When IEC acquired Albuquerque, the Company assumed responsibility for a $100 thousand Industrial Revenue Bond issued by the City of Albuquerque. Interest on the bond is paid semiannually, and principal is due in its entirety at maturity.

Events of Default

There were no events of default for the nine months ended July 1, 2016.



Contractual Principal Payments

A summary of contractual principal payments under IEC's borrowings for the next five years taking into consideration the 2013Fifth Amended Credit Agreement follows:
Debt Repayment Schedule Contractual
Principal
Payments
 Contractual
Principal
Payments
(in thousands)  
  
Twelve months ended March 27,  
2016 (1)
 $14,148
Twelve months ended June,  
2017 2,908
 $2,665
2018 4,641
2018 (1)
 9,857
2019 3,315
 3,315
2020 and thereafter 8,003
2020 2,037
2021 and thereafter 3,734
 $33,015
 $21,608
 
(1) Includes Revolver balance of $11.2$5.2 million at June 26, 2015July 1, 2016.
 
NOTE 9—DERIVATIVE FINANCIAL INSTRUMENTS  

Interest Rate Risk Management

In connection with the 2013 Credit Agreement, on January 18, 2013, the Company and M&T Bank entered into the Swap Transaction.  The Swap Transaction is for a notional amount of $14.0 million with an effective date of February 1, 2013 and a termination date of February 1, 2023.  The Swap Transaction is designed to reduce the variability of future interest payments with respect to Term Loan B by effectively fixing the annual interest rate payable on outstanding principal of Term Loan B.  Pursuant to the interest rate swap, the Company’s one month LIBOR rate is swapped for a fixed rate of 1.32%.  As more fully described in Note 8—Credit Facilities, we are partythe applicable margin on Term Loan B was fixed at 3.25% until the tenth day following the date the Company delivered its quarterly covenant calculation for the second quarter of fiscal 2016.  The applicable margin on Term Loan B based on the quarterly covenant calculation for the second quarter of fiscal 2016 was 3.25%. When the swap fixed rate is added to the Swap Transaction. Term Loan B spread of 3.25%, the Company’s interest rate applicable to Term Loan B is effectively fixed at 4.57%.

The fair value of the Swap Transactioninterest rate swap agreement represented an asseta liability of $0.1 million$163.1 thousand and $0.2 million$46.0 thousand at June 26, 2015July 1, 2016 and September 30, 2014,2015, respectively, and was estimated based on Level 2 valuation inputs.  The Company did not designate the Swap Transactionswap as a cash flow hedge at inception and therefore, the gains or losses from the changes in fair value of the derivative instrument are recognized in earnings for the periodperiods ended June 26,July 1, 2016 and September 30, 2015 within interest expense.
 

20



The fair value of the Swap Transactioninterest rate swap of $0.1 million$163.1 thousand and $0.2 million$46.0 thousand is recorded in other long term assetslong-term liability in the Consolidated Balance Sheet at June 26, 2015July 1, 2016 and September 30, 2014,2015, respectively.

NOTE 10—FAIR VALUE OF FINANCIAL INSTRUMENTS  

Financial Instruments Carried at Fair Value
 
The Company’s Swap Transaction is recorded on the balance sheet as either an asset or a liability measured at fair value.  The Company estimates the fair value of its Swap Transaction based on Level 2 valuation inputs, including fixed interest rates, LiborLIBOR implied forward interest rates and the remaining time to maturity.  At June 26, 2015,July 1, 2016, the Swap Transaction was an asseta liability with a fair value of $0.1 million.$163.1 thousand.
 
Financial Instruments Carried at Historical Cost
 
The Company’s long-term debt is not quoted.  Fair value was estimated using a discounted cash flow analysis based on Level 2 valuation inputs, including borrowing rates the Company believes are currently available to it for loans with similar terms and maturities.
 


The Company’s debt is carried at historical cost on the balance sheet.  A summary of the fair value and carrying value of fixed rate debt at period end follows:
 June 26, 2015 September 30, 2014
         July 1, 2016 September 30, 2015
 Fair Value Carrying Value Fair Value Carrying Value Fair Value Carrying Value Fair Value Carrying Value
(in thousands)                
Term Loan A 6,309
 7,315
 6,924
 8,148
 $3,746
 $3,878
 $4,412
 $4,804
Celmet Building Term Loan 966
 1,094
 1,035
 1,192
 $891
 $953
 $954
 $1,062

The fair value of the remainder of the Company’s debt approximated carrying value at June 26, 2015July 1, 2016 and September 30, 20142015 as it is variable rate debt.

NOTE 11—WARRANTY RESERVES  

IEC generally warrants its products and workmanship for up to twelve months from date of sale.  As an offset to warranty claims, the Company is sometimes able to obtain reimbursement from suppliers for warranty-related costs or losses.  Based on historical warranty claims experience and in consideration of sales trends, a reserve is maintained for estimated future warranty costs to be incurred on products and services sold through the balance sheet date.
 
A summary of additions to and charges against IEC’s warranty reserves during the period follows: 

Nine Months Ended Nine Months Ended
Warranty Reserve
June 26,
2015
 June 27,
2014
 July 1,
2016
 June 26,
2015
(in thousands)
 

 
  
  
Reserve, beginning of period
$251

$219
 $399
 $251
Provision
287

235
 126
 287
Warranty costs
(237)
(221) (228) (237)
Reserve, end of period
$301

$233
 $297
 $301
 
NOTE 12—DEFERRED GRANTS  

The Company received grants for certain facility improvements from state and local agencies in which the Company operates.  These grants reimburse the Company for a portion of the actual cost or provide in kind services in support of capital projects. 

The Company received a total of $0.9 million of grants prior to fiscal 2015. There were no deferred grants recorded in fiscal 2015 and $0.7 million of deferred grants recorded during the year ended September 30, 2014, from such grant programs.2016 or fiscal 2015.

One of the Company’s grants is a loan to grant agreement.  The Company has signed a promissory note, in the principal amount of $0.1 million, which willwas to be forgiven if certain employment targets are met at specified dates.  The portion of the Newark, NY facility are obtained at future dates.promissory note to be forgiven is calculated by applying the ratio of jobs created to jobs committed to the original note amount. If the employment targets are not obtained,met, the Company is obligated to repay a portion of the loan with interest. As the

21



Company intends to comply with these agreements, the Company has recorded the funds received as a deferred amount within other long-term liabilities on the balance sheet. 
The Company received a government grant in the amount of $0.7 million for the purchase of equipment upgrades to accommodate existing and anticipated business growth. Required employment targets at the Newark, NY facility for this grant were met as of September 30, 2014 and the Company has no further obligations under this grant.2014.

The Company is also the recipient of matching grants from two local governmental agencies related to certain renovations for one of its operating locations.  One agency is contributingcontributed in kind services and property of $0.1 million while the other is contributingcontributed cash of $0.1 million to match expenditures by the Company of at least the same amount.
 
The grants will beare amortized over the useful lives of the related fixed assets when there is reasonable assurance that the Company will meet the employment targets.  The Company recordedAccumulated amortization of $123 thousand and $14 thousand for the deferred grants forportion of the Company's loan to grant that was converted to a promissory note was adjusted in the three months ended January 1, 2016.



Grant amortization during the three and nine months ended July 1, 2016 and June 26, 2015 and June 27, 2014, respectively.follows:

  Three Months Ended Nine Months Ended
  July 1,
2016
 June 26,
2015
 July 1,
2016
 June 26,
2015
(in thousands) (unaudited) (unaudited)
Grant amortization $56
 $41
 $123
 $123

NOTE 13—STOCK-BASED COMPENSATION  

The 2010 Omnibus Incentive Compensation Plan (“2010(the “2010 Plan”) was approved by the Company’s stockholders at the January 2011 Annual Meeting of the Shareholders.Meeting.  This plan replaced IEC’s 2001 Stock Option and Incentive Plan (“2001(the “2001 Plan”), which expired in December 2011.  The 2010 Plan, which is administered by the Compensation Committee of the Board of Directors, provides for the following types of awards: incentive stock options, nonqualified options, stock appreciation rights, restricted shares, restricted stock units, performance compensation awards, cash incentive awards, director stock and other equity-based and equity-related awards.  Awards are generally granted to certain members of management and employees, as well as directors.  Under the 2010 Plan, up to 2,000,000 shares of common sharesstock may be issued over a term of ten years.
Stock-based awards granted through December 2011, were made under the 2001 Plan.  Awards granted after December 2011, were made under the 2010 Plan and future awards will be made under the 2010 Plan.

Stock-based compensation expense recorded under the plans2010 and 2001 Plans as well as the ESPP totaled $2.0$0.3 million and $0.4$2.0 million for the nine months ended July 1, 2016 and June 26, 2015, and June 27, 2014, respectively. As further discussed in Note 17—Litigation, during the nine months ended July 1, 2016, incentive compensation shares were returned by the Company's former CEO resulting in a reduction to compensation expense of $60.0 thousand. 

At June 26, 2015July 1, 2016 there were 907,389663,940 shares available to be issued fromunder the 2010 Plan.

On February 2, 2015, the Company announced that its shareholdersstockholders elected all seven Vintage Opportunity Fund, LP-nominatedLP nominated directors to the Company’s Board of Directors. This change in the Company's Board of Directors was deemed a change in control event which triggered automatic vesting for all awards outstanding under the 2010 and 2001 Plans. On the change in control date, 390,882 shares of restricted stock and 119,500 stock options vested, which resulted in stock-based compensation expense of $1.8 million.

Expenses relating to stock options that comply with certain U.S. income tax rules are neither deductible by the Company nor taxable to the employee.  Further information regarding awards granted under the 2001 Plan, 2010 Plan and employee stock purchase plan is provided below.

Stock Options
 
When options are granted, IEC estimates the fair value of the option using the Black-Scholes option pricing model and recognizes the computed value as compensation cost over the vesting period, which is typically four years.  The contractual term of options granted under the 2010 Plan is generally seven years. 
 

22




Assumptions used in the Black-Scholes model and the estimated value of options granted during the nine months ended July 1, 2016 and June 26, 2015 and June 27, 2014 are included in the table below:below.
 Nine Months Ended Nine Months Ended
Valuation of Options June 26,
2015
 June 27,
2014
 July 1,
2016
 June 26,
2015
        
Assumptions for Black-Scholes:        
Risk-free interest rate 1.29% 1.31% 1.10% 1.29%
Expected term in years 4.5
 4.1
 4.0
 4.5
Volatility 40% 49% 39% 40%
Expected annual dividends none
 none
 none
 none
        
Value of options granted:        
Number of options granted 517,145
 45,500
 10,000
 517,145
Weighted average fair value per share $1.44
 $1.62
 $1.40
 $1.44
Fair value of options granted (000's) $745
 $74
 $14
 $745
 

23



A summary of stock option activity, together with other related data, follows:
 Nine Months Ended Nine Months Ended
 June 26, 2015 June 27, 2014 July 1, 2016 June 26, 2015
Stock Options Number
of Options
 Wgtd. Avg.
Exercise
Price
 Number
of Options
 Wgtd. Avg.
Exercise
Price
 Number
of Options
 Wgtd. Avg.
Exercise
Price
 Number
of Options
 Wgtd. Avg.
Exercise
Price
                
Outstanding, beginning of period 234,000
 $4.48
 246,383
 $4.38
 717,645
 $4.40
 234,000
 $4.48
Granted 517,145
 4.14
 45,500
 4.12
 10,000
 4.64
 517,145
 4.14
Exercised (25,932) 1.87
 (18,093) 1.49
 
 
 (25,932) 1.87
Shares withheld for payment of exercise
price upon exercise of stock option
 (16,068) 1.88
 (3,407) 1.69
 
 
 (16,068) 1.88
Forfeited (8,300) 6.04
 (23,283) 5.71
 
 
 (8,300) 6.04
Expired (9,200) 6.06
 (2,850) 5.04
 (17,250) 5.82
 (9,200) 6.06
Outstanding, end of period 691,645
 $4.35
 244,250
 $4.51
 710,395
 $4.37
 691,645
 $4.35

                
For options expected to vest      
  
      
  
Number expected to vest 519,399
 $4.44
 220,987
 $4.49
 686,417
 $4.38
 519,399
 $4.44
Weighted average remaining term, in years 5.5
   3.4
  
 5.2
   5.5
 

Intrinsic value (000s)   $213
  
 $176
   $74
  
 $213

                
For exercisable options      
  
      
  
Number exercisable 205,500
 $5.01
 125,650
 $3.59
 265,286
 $4.82
 20,550
 $5.01
Weighted average remaining term, in years 3.6
   2.0
  
 4.2
   3.6
  
Intrinsic value (000s)   $70
  
 $166
   $19
  
 $70

                
For non-exercisable options      
  
      
  
Expense not yet recognized (000s)   $660
  
 $171
   $553
 

 $660
Weighted average years to be recognized 3.8
   2.6
  
 2.8
   3.8
  

                
For options exercised                
Intrinsic value (000s)   $119
  
 $59
   $
  
 $119
 


Changes in the number of non-vested options outstanding, together with other related data, follows: 
 Nine Months Ended Nine Months Ended
 June 26, 2015 June 27, 2014 July 1, 2016 June 26, 2015
Stock Options Number
of Options
 
Wgtd. Avg.
Grant Date
Fair Value
 Number
of Options
 Wgtd. Avg.
Grant Date
Fair Value
 Number
of Options
 Wgtd. Avg.
Grant Date
Fair Value
 Number
of Options
 Wgtd. Avg.
Grant Date
Fair Value
                
Non-vested, beginning of period 112,350
 $2.15
 138,350
 $2.51
 546,145
 $1.41
 112,350
 $2.15
Granted 517,145
 1.44
 45,500
 1.62
 10,000
 1.40
 517,145
 1.44
Vested (135,050) 2.08
 (41,967) 2.51
 (111,036) 1.43
 (135,050) 2.08
Forfeited (8,300) 2.35
 (23,283) 2.30
 
 
 (8,300) 2.35
Non-vested, end of period 486,145
 $1.42
 118,600
 $2.20
 445,109
 $1.41
 486,145
 $1.42
 

24



Restricted (Non-vested) Stock
 
Holders of IEC restricted stock have voting and dividend rights as of the date of grant, but until vested, the shares may be forfeited and cannot be sold or otherwise transferred.  At the end of the vesting period, which is typically four or five years (three years in the case of directors), holders have all the rights and privileges of any other IEC common stockholder.  The fair value of a share of restricted stock is its market value on the date of grant, and that value is recognized as stock compensation expense over the vesting period. 
 
A summary of restricted stock activity, together with related data, follows: 

Nine Months Ended
Nine Months Ended

June 26, 2015 June 27, 2014
July 1, 2016 June 26, 2015
Restricted (Non-vested) Stock
Number of
Non-vested
Shares

Wgtd. Avg.
Grant Date
Fair Value

Number of
Non-vested
Shares

Wgtd. Avg.
Grant Date
Fair Value

Number of
Non-vested
Shares

Wgtd. Avg.
Grant Date
Fair Value

Number of
Non-vested
Shares

Wgtd. Avg.
Grant Date
Fair Value
                
Outstanding, beginning of period
322,873
 $4.97

275,474

$5.96

54,960
 $4.23

322,873

$4.97
Granted
171,155
 5.02

155,703

4.05

187,449
 4.43

171,155

5.02
Vested
(316,539) 5.08

(80,971)
5.74

(12,300) 4.23

(316,539)
5.08
Shares withheld for payment of
taxes upon vesting of restricted stock

(133,329) 4.53

(18,615)
4.28

(150) 4.20

(133,329)
4.53
Forfeited
(1,200) 3.91

(71,103)
5.88


 

(1,200)
3.91
Outstanding, end of period
42,960
 $4.22

260,488

$5.15

229,959
 $4.39

42,960

$4.22


   
 
 
   
 
 
For non-vested shares
 
  
 

 

 
  
 

 
Expense not yet recognized (000s)
  $180

 

$725

  $988

 

$180
Weighted average remaining years for vesting
 
 2.1

 

3.0

 
 2.4

 

2.1


   
 
 
   
 
 
For shares vested
 
  
 

 

 
  
 

 
Aggregate fair value on vesting dates (000s)
 
 $2,062

 

$421

 
 $47

 

$2,062
 
Employee Stock Purchase Plan
 
The Company administers an employee stock purchase plan (“ESPP”)ESPP that provides for a discounted stock purchase price.  On May 21, 2013, the Compensation Committee of the Company’s Board of Directors suspended operation of the ESPP indefinitely in connection with the Prior Restatement (including unavailability of the registration statement covering shares offered under the plan due to the failure of the Company to be current in its filings with the SEC until the Company filed its Form 10-K on December 24, 2013).  The ESPP was reinstated effective October 1, 2014.  On February 13, 2015, the Compensation Committee of the Company’s Board of Directors suspended operation of the ESPP indefinitely in connection with the 2014 Restatements described in Note 2—Restatement1—Our Business and Summary of Deferred Tax Asset Valuation Allowance and Excess and Obsolete Inventory Reserve (including unavailabilitySignificant Accounting Policies. The Compensation Committee of the registration statement covering shares offered underCompany's Board of Directors reinstated the plan dueESPP on December 2, 2015; however, participants were not able to contribute to the failure of the Company to be current in its filings with the SEC).ESPP until January 2016.



Employees currently receive a 10% discount on stock purchases through the ESPP. Employee contributions to the plan, net of withdrawals were $13.8 thousand and $8.0 thousand for the nine months ended July 1, 2016 and June 26, 2015.2015, respectively. Compensation expense recognized under the ESPP was $1.8 thousand and $1.0 thousand for the nine months ended July 1, 2016 and June 26, 2015. There were no employee contributions or compensation expense recognized under the ESPP during the nine months ended June 27, 2014.2015, respectively.

Stock Issued to Board Members
 
In addition to annual grants of restricted stock, included in the table above, Board members may elect to have their meeting fees paid in the form of shares of the Company’s common stock.   In connection with the restatementPrior Restatement of the Company’s financial statements, described herein (including unavailability of the registration statement covering shares offered under the 2010 Plan due to the failure of the Company to be current in its filings with the SEC until the Company filed its Form 10-K on December 24, 2013), the Company determined not to pay, and has not paid, any meeting fees in stock during the period since May 21, 2013 through the third quarter of fiscal 2015.2013. 



25



NOTE 14—RETIREMENT PLAN  

The Company administers a retirement savings plan for the benefit of its eligible employees and their beneficiaries under the provisions of Sections 401(a) and (k) of the Internal Revenue Code.  Eligible employees may contribute a portion of their compensation to the plan, and the Company is permitted to make discretionary contributions as determined by the Board of Directors.  During the the first nine months of fiscal 2015, theThe Company contributedcontributes 25% of the first 6% contributed by all employees at all locations. During the first nine months of fiscal 2014, for its Albuquerque operating location only, the Company contributed 25% of the first 6% contributed by employees. Contributionscontributions during the nine months ended July 1, 2016 and June 26, 2015 and June 27, 2014 totaled $200$195 thousand and $27$200 thousand, respectively.

NOTE 15—INCOME TAXES  

Provision for income taxes during the three and nine months ended July 1, 2016 and June 26, 2015 and June 27, 2014 follows:
 Three Months Ended Nine Months Ended Three Months Ended Nine Months Ended
Income Tax Provision/Benefit June 26,
2015
 June 27,
2014
 June 26,
2015
 June 27,
2014
 July 1,
2016
 June 26,
2015
 July 1,
2016
 June 26,
2015
(in thousands)  
 (restated)   (restated)  
 
    
Provision for/(benefit from) income taxes $
 $
 $
 $13,039
 $(6) $(4) $(6) $(4)
 
The Company restated to recordhas recorded a full valuation allowance on all deferred tax assets during the second quarter of fiscal 2014. The restatement is further discussed in Note 2—Restatement of Deferred Tax Asset Valuation Allowance and Excess and Obsolete Inventory Reserve.

assets. Although we have recorded a full valuation allowance for all deferred tax assets, including net operating loss carryforwards ("NOLs"(“NOLs”), these NOLs remain available to the Company to offset taxable income and reduce tax payments. IEC has federal NOLs for income tax purposes of approximately $16.3$35.8 million at September 30, 2014,2015, expiring mainly in years 2021 through 2025, with a small portion expiring in 2034.2026.
 
At September 30, 2014,2015, the Company also had state NOLs of $27.7$27.9 million, expiring mainly in years 2021 through 2025 and $1.2 million of New York Statestate investment tax and other credit carryforwards, expiring in various years through 2028.  The credits cannot be utilized until the New York NOL is exhausted. Recent New York state corporate tax reform has resulted in the reduction ofreduced the business income base rate for qualified manufacturers in New York state to 0% beginning in fiscal 2015 for IEC. As a result of this legislation, it is more likely thanthe Company has not that the New Yorkattributed any value to its state NOLs and credits will not be realized.NOLs.

Due to the Company's NOLs, a provision for pre-tax income was not recorded in the second quarter of fiscal 2015.

NOTE 16—MARKET SECTORS AND MAJOR CUSTOMERS  

A summary of sales, according to the market sector within which IEC's customers operate, follows: 
 Three Months Ended Nine Months Ended Three Months Ended Nine Months Ended
% of Sales by Sector June 26,
2015
 June 27,
2014
 June 26,
2015
 June 27,
2014
 July 1,
2016
 June 26,
2015
 July 1,
2016
 June 26,
2015
  
Aerospace & Defense (previously Military & Aerospace) 35% 50% 40% 50%
Aerospace & Defense 43% 32% 39% 37%
Medical 32% 22% 30% 19% 39% 34% 44% 32%
Industrial 30% 22% 27% 25% 16% 32% 15% 28%
Communications & Other 3% 6% 3% 6% 2% 2% 2% 3%

 100% 100% 100% 100% 100% 100% 100% 100%

Two individual customers each represented 10% or more of sales for the nine months ended July 1, 2016. Both customers were from the Medical sector and represented 17% of sales each. Three individual customers each represented 10% or more of sales for the nine months ended June 26, 2015.  One customer in the industrialIndustrial sector represented 18%19% of sales, while two customers in the medicalMedical sector represented 13%14% and 11% of sales. Two individual customers represented 10% or more of sales for the nine months ended June 27, 2014.  One customer in the Industrial sector represented 15% of sales and one customer in the Medical sector represented 12% of sales for the nine months ended June 27, 2014.26, 2015.


26




Four individual customers represented 10% or more of receivables and accounted for 44% of outstanding balances at July 1, 2016. Three individual customers represented 10% or more of receivables and accounted for 43% of the outstanding balances at June 26, 2015. Three

Credit risk associated with individual customers represented 10% or more of receivablesis periodically evaluated by analyzing the entity’s financial condition and accounted for 37% of the outstanding balances at June 27, 2014.payment history.  Customers generally are not required to post collateral.

NOTE 17—LITIGATION

On June 28, 2016, the Company consented to the entry of a settled administrative order by the U.S. Securities and Exchange Commission (the “SEC”) alleging violations of the antifraud, periodic and current reporting, internal controls, and books-and-records provisions of the federal securities laws. As part of the settled administrative order, the Company (i) neither admitted nor denied the SEC’s findings, (ii) paid a penalty of $200,000, and (iii) agreed to cease-and-desist from committing or causing any violations or future violations of those provisions.

In addition, the settled administrative order included settled charges and sanctions against two individuals who are no longer associated with the Company - a former Executive Vice President of the Company and a former Controller of SCB that was the subject of the Prior Restatement.

In connection with the Prior Restatement, W. Barry Gilbert, our former chief executive officer and director, voluntarily returned to the Audit Committee conducted an independent reviewCompany certain incentive compensation and the proceeds from certain sales of the underlying factsCompany's common stock. These transfers, which were made during the three months ended January 1, 2016, were in the form of cash of $42 thousand and circumstances, andshares of common stock valued at $60 thousand.

Effective March 16, 2016, the Company is respondingentered into a separation agreement with Mr. Gilbert (the “Separation Agreement”). Pursuant to a formal investigation by the staffterms of the SECSeparation Agreement, Mr. Gilbert received a separation benefit of $500 thousand that was paid on March 16, 2016 and $200 thousand paid on May 16, 2016, and he will receive $100 thousand payable on both March 16, 2017 and March 16, 2018, and $75 thousand payable on each of March 16, 2019 and March 16, 2020. The expense associated with the separation agreement is included in selling and administrative expenses, a portion of which was recorded in the prior fiscal year. The remaining unpaid amount is included in accrued payroll and related expenses.

The separation benefit is subject to acceleration in the event of certain changes in control of the Company. The Company also released Mr. Gilbert from any and all claims and causes of action directly or indirectly related to Mr. Gilbert’s employment relationship with the Company. In consideration of the foregoing, Mr. Gilbert agreed to release the Company from any and all claims and causes of action arising out of or relating to his previous employment with the Prior Restatement andCompany, as well as certain other matters. The Company is unable to predict what action, if any, might be takencovenants set forth in the future by the SEC or its staff as a result of the investigation or what impact the cost of responding to the SEC might have on the Company’s financial position, results of operations, or cash flows.Separation Agreement.

From time to time, the Company may be involved in other legal action in the ordinary course of its business, but management does not believe that any such other proceedings commenced through the date of the financial statements included in this Form 10-Q, individually or in the aggregate, will have material adverse effect on the Company’s consolidated financial position.

NOTE 18—COMMITMENTS AND CONTINGENCIES   

Loss Contingencies

As discussed in Note 17—Litigation, on June 28, 2016, the Company consented to the entry of a settled administrative order by the SEC. The settled administrative order included settled charges and sanctions against two individuals who are no longer associated with the Company. The Company has insurance that covers the Company and certain individuals (including the two former employees discussed above) for certain expenses incurred in connection with the SEC investigation. Through July 1, 2016, the Company has received aggregate reimbursements from its primary carrier of approximately $9.0 million. The Company’s insurance policy contains exclusion provisions that are triggered when “a final, non-appealable adjudication” in an underlying proceeding or action “establishes” certain conduct, including “any deliberately fraudulent act or omission or any willful violation of any statute or regulation.” The Company's resolution of the SEC investigation was on a “no admit or deny” basis and, as such, does not “establish” any conduct as part of any “final, non-appealable adjudication.” Accordingly, the Company has concluded it is not probable that the insurance carrier would (i) seek to recoup the reimbursement of expenses it has made to the Company or (ii) be successful in the event that recoupment were sought.

Purchase Commitments
 
During August 2011, one of IEC's operating units entered into a five-year agreement with one of its suppliers to purchase a minimum volume of materials in exchange for receiving favorable pricing on the unit's purchases. The agreement was


subsequently amended to extend through September 30, 2018.  In the event the unit's cumulative purchases do not equal or exceed stated minimums, the supplier has a right to terminate the agreement and the IEC unit would be obligated to pay an early termination fee that declines from $365 thousand to zero over the term of the agreement.  As of the date of this Form 10-Q, the Company expects to exceed the minimum purchase requirements under the agreement, thereby avoiding any termination fee.

NOTE 19—SUBSEQUENT EVENTS

Subsequent to third quarter of fiscal 2015, the Company sold its Southern California Braiding Company, Inc. (SCB) business to DCX-Chol Enterprises, Inc. ("DCX"), a provider of engineered high performance interconnect products, for a purchase price of approximately $2.5 million. As previously disclosed, Southern California Braiding, Inc., a wholly owned subsidiary of the Company, entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”), effective as of July 9, 2015, by and between SCB and DCX, whereby DCX purchased the multi-conductor stranded copper cable and harness assemblies manufacturing and servicing business previously operated by SCB. Prior to this transaction, there was not a material relationship between the Company and DCX or between DCX and any officer, director or affiliate of the Company.

Pursuant to the Asset Purchase Agreement, SCB sold substantially all of its assets to DCX for a net cash payment of $2.3 million and the assumption by DCX of certain obligations and liabilities of SCB. The cash payment is net of certain pro rations and transaction costs. The Asset Purchase Agreement contains indemnification obligations of each party with respect to breaches of representations, warranties and covenants and certain other specified matters.


27



The Company is still evaluating whether SCB will be reported as discontinued operations in subsequent periods. A summary of SCB's operating results and total assets follows:

 Three Months Ended Nine Months Ended
 June 26,
2015
 June 27,
2014
 June 26,
2015
 June 27,
2014
 (unaudited) (restated) (unaudited) (restated)
Net sales1,867
 3,819
 5,215
 10,698
Gross profit14
 663
 (583) 1,632
Income/(loss) before income taxes(4,389) 286
 (5,727) (33)
        
        
 June 26,
2015
 September 30,
2014
    
 (unaudited) (restated)    
Total Assets3,584
 9,567
    



28




Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
The information in this Management's Discussion and Analysis should be read in conjunction with the accompanying unaudited consolidated financial statements and notes.  All references to Notes are to the accompanying consolidated financial statements and Notes included in this Quarterly Report on Form 10-Q (“Form 10-Q”).
 
Cautionary Note Regarding Forward-Looking Statements

References in this report to “IEC”, the “Company”, “we”, “our”, or “us” mean IEC Electronics Corp. and its subsidiaries except where the context otherwise requires. This Form 10-Q contains certain statements that are, or may be deemed to be,forward-looking statements. In some cases, you can identify forward-looking statements withinby terms such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the meaningnegative of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934, and are made in reliance upon the protections provided by such Acts for forward-looking statements.these terms or other similar expressions. These forward-looking statements (such as when we describe what we “believe”, “expect” or “anticipate” will occur, and other similar statements) include, but are not limited to, statements regarding future sales and operating results, future prospects, the capabilities and capacities of business operations, any financial or other guidance and all statements that are not based on historical fact, but rather reflect our current expectations concerning future results and events. The ultimate correctness of these forward-looking statements is dependent upon a number of known and unknown risks and events and is subject to various uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements.

The following important factors, among others, could affect future results and events, causing those results and events to differ materially from those views expressed or implied in our forward-looking statements: additional information that may arise as a result of the 2014 Restatements; our ability to successfully remediate material weaknesses in our internal controls; litigation and governmental investigations or proceedings arising out of or relating to accounting and financial reporting matters; business conditions and growth or contraction in our customers'customers’ industries, the electronic manufacturing services industry and the general economy; variability of our operating results; our ability to control our material, labor and other costs; our dependence on a limited number of major customers; the potential consolidation of our customer base; availability of component supplies; dependence on certain industries; variability and timing of customer requirements; technological;technological, engineering and other start-up issues related to new programs and products;products, uncertainties as to availability and timing of governmental funding for our customers; the impact of government regulations, including FDA regulations; the types and mix of sales to our customers; our ability to assimilate acquired businesses and to achieve the anticipated benefits of such acquisitions;intellectual property litigation; unforeseen product failures and the potential product liability claims that may be associated with such failures; the availability of capital and other economic, business and competitive factors affecting our customers, our industry and business generally; failure or breach of our information technology systems; and natural disasters; and other factors that we may not have currently identified or quantified.disasters. Any one or more of such risks and uncertainties could have a material adverse effect on us or the value of our common stock. For a further list and description of various risks, relevant factors and uncertainties that could cause future results or events to differ materially from those expressed or implied in our forward-looking statements, see the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections elsewhere in this Form 10-Q and other filings with the Securities and Exchange Commission (the “SEC”).

Except as required by law, all forward lookingAll forward-looking statements included in this Form 10-QForm-10-Q are made only as of the date indicated or as of the date of this Form 10-Q. We do not undertake noany obligation to, and may not, publicly update or correct any forward-looking statements whether as a result of new information, futureto reflect events or otherwise.circumstances that subsequently occur or which we hereafter become aware of, except as required by law. New risks and uncertainties arise from time to time and we cannot predict thosethese events or how they may affect us.us and cause actual results to differ materially from those expressed or implied by our forward-looking statements. Therefore, you should not rely on our forward-looking statements as predictions of future events. When considering these risks, uncertainties and assumptions, you should keep in mind the cautionary statements contained elsewhere in this report and in any documents incorporated herein by reference. In particular, you should consider the Risk Factors identified in Item 11A of the Company’s Annual Report on Form 10-K/A10-K for the fiscal year ended September 30, 2014 and in the Company’s subsequently filed SEC reports.2015. You should read this document and the documents that we incorporate by reference into this Report on Form 10-Q completely and with the understanding that our actual future results may be materially different from what we expect. All forward-looking statements attributable to us are expressly qualified by these cautionary statements.

Overview
 
IEC Electronics Corp. conducts business directly, as well as through its subsidiaries and divisions, Wire and Cable, Albuquerque, SCB, Celmet and DRTLATL described in Note 1—Our Business and Summary of Significant Accounting Policies – Our Business and Consolidation. As discussed further in Note 2—SCB Divestiture and Discontinued Operations, the operations of SCB, the Company's wholly owned subsidiary, were divested during the fourth quarter of fiscal 2015.
 
We are a provider of electronic contract manufacturing services (“EMS”) to companies in various industries that require advanced technology for mission-critical applications.  We specialize in the custom manufacture of high reliability, complex


circuit board and system-level assemblies; a wide array of cable and wire harness assemblies capable of withstanding extreme environments; and precision metal components. Wire and Cable is also located in Newark, NY. Our Albuquerque operation occupies an important niche in the military and defense markets, supporting its customers by manufacturing complex circuit board and system-level assemblies and provide laboratory services for advanced researchmanaging their legacy products and testing.  programs. Celmet, a division of IEC, manufactures metal chassis and assemblies and is located in Rochester, NY.

We believe we excel where quality and reliability are of paramount importance and when low-to-medium volume, high-mix production is the norm.  We utilize state-of-the-art, automated circuit board assembly equipment together with a full complement of high-reliability manufacturing stress testing methods.  With our customers at the center of everything we do, we believe we have created a high-intensity, rapid response culture capable of

29



reacting and adapting to their ever-changing needs.  Our customer-centric approach offers a high degree of flexibility while simultaneously complying with rigorous quality and on-time delivery standards.  While many EMS services are viewed as commodities, we believe we set ourselves apart through an uncommon mix of capabilities including: 

A technology center located in Newark, NY that combines dedicated prototype manufacturing with an on-site laboratory capable of solving our customers' complex design and reliability issues,materials analysis lab, enabling the seamless transition conceptfrom design to production.
An in-house engineering development team capable of designing and buildingIn-house, custom, functional testing systems to certify the reliabilityand troubleshooting of our customers' complex system-level products andassemblies in support of end-order fulfillment.
A testing services laboratory at our subsidiary, ATL that enables us to provide ourassist customers within mitigating the risk of purchasing counterfeit parts.
Build-to-print precision sheet metal and complex failure analysiswire harness assemblies supporting just-in-time delivery of electronic components as well as component risk mitigation planning for obsolete and suspect parts utilized in life threatening and mission-critical systems.critical end-market, system-level electronics.
A Lean/Six Sigma continuous improvement program supported by a team of Six Sigma Blackbelts delivering best-in-class results.
Proprietary software-driven Web Portal which provides customers real-time access to their critical, project specific data.

We primarily serve the aerospace & defense (previously discussed as military & aerospace), medical, industrial and communications markets. We focus on developing relationships with customers who manufacture advanced technology products and who are unlikely to utilize offshore suppliers due to the proprietary nature of their products, governmental restrictions or volume considerations.

We have continued to add new customers and markets, and our customer base is stronger and more diverse as a result. We proactively invest in areas we view as important for our continued long-term growth. IEC is ISO 9001:2008 certified. FourAll of our units (IEC and Wire and Cable in Newark, NY; Albuquerque in NM; and SCB in Bell Gardens, CA) are AS9100 certified to serve the military and commercial aerospace market sector, andfacilities are ITAR registered. In addition, the Company’s locations in Newark, NY and Albuquerque, NM are Nadcap accredited for electronics manufacturing to support the most stringent quality requirements of the aerospace industry and the Newark, NY location is ISO 13485 certified to serve the medical market sector. Our Newark, NY location is also an NSA approved supplier under the COMSEC standard and its environmental systems are ISO 14001:2004 certified. DRTLATL in Albuquerque, NM is ISO 17025 accredited, which is the international standard covering testing and calibration laboratories. Albuquerque and SCB also performperforms work per NASA-STD-8739 and J-STD-001ES space standards. During fiscal 2014, our Newark, NY and Albuquerque, NM facilities were awarded the IPC-J-STD-001/IPC-A-610 Qualified Manufacturers Listing. During fiscal 2015, our Newark, NY and Albuquerque, NM facilities were awarded the IPC/WHMA-A-620 Qualified Manufacturers Listing. The Company’s locations in Newark, NY and Albuquerque, NM are AS9100C certified. ATL has been certified as an IPC-approved Validation Services Test Laboratory.
The technical expertise of our experienced workforce enables us to build some of the most advanced electronic, wire & cable, and precision metal systems sought by original equipment manufacturers (“OEMs”).

Prior Restatement
 
The Company previously disclosed in its Annual Report on Form 10-K/A and Quarterly Report on Form 10-Q/A, both filed with the SEC on July 3, 2013, that it restated its financial statements for the periods described therein because the Company was incorrectly accounting for work-in-process inventory at one of its subsidiaries, SCB (the "Prior Restatement"“Prior Restatement”).  The Company restated: (i) its previously issued consolidated financial statements for the fiscal year ended September 30, 2012 (“FY 2012”), as included in the Company’s Annual Report on Form 10-K for FY 2012, as well as the unaudited interim consolidated financial statements as of and for the fiscal quarter and year-to-date periods ended December 30, 2011 (“Q1-2012”), March 30, 2012 (“Q2-2012”) and June 29, 2012 (“Q3-2012”) (collectively, the “2012 Restated Periods”) as included in its Quarterly Reports on Form 10-Q for Q-1 2012, Q-2 2012 and Q-3 2012, and (ii) its previously issued financial statements for the quarter ended December 28, 2012 (“Q1-2013”) as included in its Quarterly Report on Form 10-Q for Q1-2013. 



2014 Restatements

As discussed further in this Management’s Discussion and Analysis and in Note 2—Restatement of Deferred Tax Asset Valuation Allowance and Excess and Obsolete Inventory Reserve, weWe restated our previously issued consolidated financial statements for fiscal year ended September 30, 2014 (“FY 2014”) and our unaudited interim financial statements for the fiscal quarters ended March 28, 2014 (“Q2-2014”) and June 27, 2014 (“Q3-2014”) due to an error in the valuation allowance on deferred income tax assets resulting in an understatement of income tax expense and a corresponding overstatement of deferred income tax assets during Q2-2014 of approximately $14.0 million. Income tax expense was overstated and deferred income tax assets were understated by $3.0 thousand and $1.8 million in Q3-2014 and the fiscal quarter ended September 30, 2014 ("Q4-2014"(“Q4-2014”), respectively. In FY 2014, income tax expense was understated and deferred income tax assets were overstated by approximately $12.3 million.

In addition, we restated our previously issued consolidated financial statements for FY 2014, and the unaudited interim financial statements for Q3-2014, Q2-2014 and the fiscal quarter ended December 27, 2013 ("Q1-2014"(“Q1-2014”) due to an error in the estimation of the excess and obsolete inventory reserve at two operating locations, which resulted in an understatement of cost of goods sold and overstatement of inventory. Cost of goods sold was understated by approximately $0.2 million, $0.1 million, $0.1 million and $0.3 million in Q1-2014, Q2-2014, Q3-2014 and Q4-2014, respectively. Inventory was overstated by approximately $0.2 million, $0.4 million, $0.4 million and $0.7 million as of the end of Q1-2014, Q2-2014, Q3-2014 and Q4-2014, respectively. For FY 2014, cost of goods sold was understated and inventory was overstated by approximately

30



$0.7 $0.7 million. We refer to the restatements related to the deferred tax asset valuation allowance and excess and obsolete inventory reserve as the 2014 Restatements and together with the Prior Restatement, the Restatements.“Restatements”.

Three Months Results
 
A summary of selected income statement amounts for the three months ended follows:

Three Months Ended
Three Months Ended
Income Statement Data
June 26,
2015
 June 27,
2014

July 1,
2016
 June 26,
2015
(in thousands)
  (restated)
  
Net sales
$34,444
 $32,992

$32,508
 $32,577


   
   
Gross profit
4,703
 3,795

5,463
 4,689
Selling and administrative expenses
4,049
 3,195

3,463
 3,689
Impairment of goodwill and other intangibles 4,057
 
Restatement and related expenses
298
 102

12
 312
Interest and financing expense
316
 558

389
 316
Other expense/(income)

 
Income/(loss) before income taxes
(4,017) (60)
Income/(loss) from continuing operations before income taxes
1,599
 372
Provision for/(benefit from) income taxes

 
 (6) (4)
Income/(loss) from continuing operations 1,605
 376
Loss on discontinued operations, net 
 (4,392)
Net income/(loss)
$(4,017) $(60) $1,605
 $(4,016)
 
A summary of sales, according to the market sector within which IEC's customers operate, follows:
 Three Months Ended Three Months Ended
% of Sales by Sector June 26,
2015
 June 27,
2014
 July 1,
2016
 June 26,
2015
  
Aerospace & Defense (previously Military & Aerospace) 35% 50%
Aerospace & Defense 43% 32%
Medical 32% 22% 39% 34%
Industrial 30% 22% 16% 32%
Communications & Other 3% 6% 2% 2%

 100% 100% 100% 100%
 
Revenue increased in the third quarter of fiscal 2015 by $1.5 million or 4.4% aswas flat compared to the third quarter of the prior fiscal year.2015. Increases in the medical market sector and industrial market sector of $3.9 million and $2.8 million, respectively were partially offset by decreases in the aerospace & defense market sector and medical market sector of $4.2$3.5 million and $1.7 million, respectively were offset by a decrease of $5.2 million in the industrial market sector. Revenue for the communications & other market sector of $1.1 million.was flat.

Revenue for the medical market sector increased $3.9 million primarily due to increases in demand. Higher demand from our medical customer that was awaiting FDA approval in fiscal 2014 caused an increase of $4.3 million. In the third quarter of the prior fiscal year, the hold was lifted and the customer's testing was completed in the fourth quarter. We began shipping production orders late in the fourth quarter of fiscal 2014 and volume continued to increase throughout the first three quarters of fiscal 2015. Revenue for another medical customer decreased $1.2 million due to lower demand. The remaining increase was due to revenue from new programs with existing customers of $0.5 million and increased demand of $0.3 million at another customer.

The net increase in the industrial market sector of $2.8 million resulted primarily from new programs with three existing customers. We expect the volume for some of these new programs to decrease as our customers plan to source a portion of the programs from another contract manufacturer. Revenue from one new customer increased revenue by $0.2 million. These increases were partially offset by a net decrease in revenue at three other customers caused by fluctuations in demand.

Various decreasesincreases and increasesdecreases for our aerospace & defense customers resulted in a net decreaseincrease of $4.2$3.5 million. Programs frequently fluctuate in demand or end and are replaced by new programs. Aggregate decreasesincreases of $6.8$5.3 million were partially offset by increases$1.9 million in decreases from other customers. Higher demand from several of our customers increased revenue by $3.8 million. New programs from existing customers caused increases of $1.5 million. Lower demand from several of our customers caused decreases of $4.0$1.6 million. A

31



portion of this demand decrease is attributable to lower quality and on time delivery ratings with two customers of our SCB location. The loss of two programs caused a $0.4 million decreaseprogram and the winding down of two other programs caused an additional decrease of $0.4 million. Aanother program for an existing customer that occurred in 2014 and is not expected to recur caused a decrease of $0.4 million. Two lost customers, one of which was due to a customer facility shut down, caused an additional decrease of $0.4 million. Our decision to end certain programs with two customers due primarily to lack of profitability caused an aggregate decrease of $1.2$0.3 million.

The decreasesRevenue for somethe medical market sector increased $1.7 million primarily due to increases in demand. Higher demand from four of our aerospace & defense customers increased revenue by $2.0 million. This includes two customer programs that were in the prototype stage and ramping in fiscal 2015. These increases were partially offset by increases at several other customers. Highera decrease in demand at existingfrom one of our customers resulting in an increase of $2.1 million. New programs from existing customers increased revenue by $0.5 million. An increase of $0.3 million was due to a program for an existing customer in fiscal 2015 that did not occur in fiscal 2014 and is not expected to recur in the future.million.

The net decrease in the communications & otherindustrial market sector was $1.1of $5.2 million comparedresulted primarily from lower demand. As anticipated during 2015, one of our customers began sourcing more product from an alternate source in China which decreased revenue by $4.4 million. We expect this customer to the third quarter of the prior fiscal year. Lower demandcontinue to source product from two customersChina for programs we are currently supporting. A lost customer caused a decrease of $1.1 million. Our decision to end a customer relationships due to lack of profitability resulted in an additional decrease of $0.6 million. Higher demand at existing customers as well as revenue from a new customer offset $0.5$0.2 million of the decreases.decrease. The remaining decrease was due to other customer fluctuations.

Our third quarter gross profit increased $0.9 million to 13.7%was 16.8% of sales from 11.5% of salesversus 14.4% in the third quarter of the prior fiscal year. Gross profitSeveral factors lead to the improvement was driven largely byin gross margin. The main drivers were a reduction in overhead including lower inventory reserve expense and depreciation, as well as improved labor costs. Improvements in process and an increasedefficiencies. Lower labor costs were the result of the continued focus on labor efficiency lowered headcount and reduced overtime. Increased revenue allowed better leverage of our overhead. In addition to the improvements in labor and overhead costs, we also experienced a slight improvement in reducing material costs as a percent of revenue.lean manufacturing.

Selling and administrative ("(“S&A"&A”) expenses areexpense is presented excluding restatementRestatement and related expenses as well as the impairment of goodwill and other intangible assets as discussed below. S&A expense increased $0.9decreased $0.2 million, and represented 11.8%10.7% of sales in the third quarter of fiscal 2015,2016, compared to 9.7%11.3% of sales in the same quarter of the prior fiscal year. The increasedecrease in S&A expensesexpense was primarily due to increased payroll andlower labor costs related benefitsto some headcount reductions over the course of the year as well as an increase in bad debt expense. Payroll and related benefits increased $0.4 million primarily related to increased medical insurance and temporary wage expense, primarily due to additional finance resources required for the 2014 Restatement and proxy contest. We realized income of $0.2 million in the same quarter of the prior fiscal year for bad debt versus less than $0.1 million of expense in the third quarter of fiscal 2015. During the third fiscal quarter of fiscal 2015, we incurred expenses related to the divestiture of Southern California Braiding, which closed subsequent to the end of the third fiscal quarter as further discussed in Note 8—Credit Facilities. In addition, $0.1 million of costs associated with the lender requirements related to the Sixth Amendment to the 2013 Credit Agreement were incurred during the third quarter of fiscal 2015.

During the third quarter of fiscal 2015, we recorded an impairment charge of $4.1 million to our SCB reporting unit which fully impaired goodwill and intangibles and impaired fixed assets by $0.1 million. IEC received an offer to purchase substantially all the assets and the assume certain liabilities of SCB for approximately $2.5 million during the third quartet of fiscal 2015. As we were willing to accept $2.5 million, we considered this to be an indication of fair value and as such, adjusted the reporting unit's assets to fair value.lower professional fees.

Restatement and related expenses of $0.3 million in the third quarter of fiscal 2015 represent third party legal and accounting fees directly attributable to the Restatements as well as other matters arising from the Prior Restatement including those more fully described in Note 17—Litigation. WeRestatement and related expenses, net of reimbursement received were $12 thousand in the third quarter of fiscal 2016, which is a decrease of $0.3 million compared to the third quarter of the prior fiscal year. As discussed in Note 17—Litigation we have a settled administrative order with the SEC and therefore do not anticipate significant continued legal expenses due to the Prior Restatement and other matters (including the formal SEC investigation) for the foreseeable future. While we anticipate certain of these expenses will continue to be reimbursed, any such reimbursement for future expenses will vary with the circumstances under which such expenses are incurred and their respective amounts. In the current fiscal year, we have also incurred restatement and related expenses related to fees for the reaudit of fiscal 2014 due to the 2014 Restatements.going forward.

Interest expense decreasedincreased by $0.2$0.1 million compared to the same quarter of the prior fiscal year. The net impact of adjusting the interest rate swap to fair value contributed $0.2in the third quarter of fiscal 2016 was additional expense of $0.1 million compared to the decrease in expensea benefit of $0.1 million in the third quarter of the currentprior fiscal yearyear. This increase was partially offset by a decrease due to lower average outstanding debt, slightly offset by a higher weighted average interest rate. Our average outstanding debt balances decreased by $10.8 million in the third quarter of fiscal 2016 compared to the priorthird quarter of fiscal year.2015. The weighted average interest rate on IEC's debt, excluding the impact of the interest rate swap, was 0.08%0.16% higher during the third quarter of fiscal 2015 than in2016 compared to the third quarter of the prior fiscal year. Our average outstanding debt balances increased by $1.3 million in the third quarter of fiscal 2015 compared to the third fiscal 2014. During the third quarter of the current fiscal year there was a decrease in debt covenant waiver fees compared to the same quarter of the prior fiscal year. Cash paid for interest was approximately $0.4 million for both the third quarter of fiscal 2015 and fiscal 2014. Detailed information regarding our borrowings including a summary of modifications to the Fourth Amended and Restated Credit Facility Agreement and debt covenant compliance, is provided in Note 8—Credit Facilities.

32



There was no material income tax expense or benefit in the third quarter of fiscal 2016 or fiscal 2015 as we have net operating loss (“NOL”) carryforwards to offset any current tax expense and a full valuation on all deferred tax assets. The full valuation allowance was recorded in the second quarter of fiscal 2014.
 
With respect to tax payments, in the near term, IEC expects to be sheltered by sizable NOL carryforwards for federal income tax purposes. At the end of fiscal 2014,2015, the NOL carryforwards amounted to approximately $16.3$35.8 million. The NOL carryforwards expire in varying amounts between 2021 and 2025, with a small portion expiring in 2034,2026, unless utilized prior to these dates.

Discontinued operations is further discussed in Note 2—SCB Divestiture and Discontinued Operations. There was no loss on discontinued operations in the the third quarter of fiscal 2016. The loss on discontinued operations was $4.4 million in the third quarter of fiscal 2015.



Nine Months Results
 
A summary of selected income statement amounts for the nine months ended follows:
 Nine Months Ended Nine Months Ended
Income Statement Data June 26,
2015
 June 27,
2014
 July 1,
2016
 June 26,
2015
(in thousands)   (restated)    
Net sales $98,276
 $99,934
 $98,590
 $93,061

        
Gross profit 10,519
 11,816
 17,017
 11,117
Selling and administrative expenses 14,346
 10,938
 11,218
 13,255
Impairment of goodwill and other intangibles 4,057
 
Restatement and related expenses 948
 2,516
 4
 953
Interest and financing expense 1,516
 1,410
 1,191
 1,516
Other expense/(income) 
 18
Income/(loss) before income taxes (10,348) (3,066)
Income/(loss) from continuing operations before income taxes 4,604
 (4,607)
Provision for/(benefit from) income taxes 
 13,039
 (6) (4)
Income/(loss) from continuing operations 4,610
 (4,603)
Loss on discontinued operations, net 
 (5,745)
Net income/(loss) $(10,348) $(16,105) $4,610
 $(10,348)

A summary of sales, according to the market sector within which IEC's customers operate, follows:
 Nine Months Ended Nine Months Ended
% of Sales by Sector June 26,
2015
 June 27,
2014
 July 1,
2016
 June 26,
2015
  
Aerospace & Defense (previously Military & Aerospace) 40% 50%
Aerospace & Defense 39% 37%
Medical 30% 19% 44% 32%
Industrial 27% 25% 15% 28%
Communications & Other 3% 6% 2% 3%

 100% 100% 100% 100%

Revenue decreasedincreased in the first nine months of fiscal 20152016 by $1.7$5.5 million or 1.7%5.9% as compared to the first nine months of the prior fiscal year. DecreasesIncreases in the medical market sector and aerospace & defense market sector of $13.0 million and $4.3 million, respectively, were partially offset by decreases in the industrial market sector and communications & other market sectors were $10.4sector of $11.3 million and $3.5$0.4 million, respectively. These decreases were partially offset by increases in the medical and industrial market sectors. The medical market sector increased $10.9 million and the industrial market sector increased $1.4 million.
Various decreases and increases for our aerospace & defense customers resulted in a net decrease of $10.4 million. Programs frequently fluctuate in demand or end and are replaced by new programs. Aggregate decreases of $17.2 million were partially offset by increases from other customers. Lower demand at several of our customers caused a decrease of $10.7 million. A portion of this demand decrease is attributable to lower quality and on time delivery ratings with two customers of our SCB location. The loss of five programs caused a decrease of $2.0 million and the winding down of two programs caused $1.1 million of the decrease. Our decision to end certain programs with customers due primarily to lack of profitability caused an aggregate decrease of $1.8 million. Two lost customers, one of which was due to a customer facility shut down, caused a decrease of $0.8 million. In addition, one time orders fulfilled in the first nine months of the prior year caused a revenue decrease of $0.8 million.


33



These decreases were partially offset by increases at several other customers. New programs and increased demand from existing customers increased revenue by $2.5 million and $2.3 million, respectively. Revenue of $1.6 million in the first nine months of fiscal 2015 was due to a program for an existing customer that did not occur in fiscal 2014 and is not expected to recur in the future.

Revenue for the communications & other market sector decreased $3.5 million. The decision to end two customer relationships, one of which was due to lack of profitability, resulted in an aggregate decrease of $2.6 million. Lower demand from one customer due to a shift in their business model decreased revenue by $1.4 million. Lower demand from two other customers decreased revenue by $0.4 million. These decreases were partially offset by increased demand from existing customers of $0.7 million and revenue from a new customer of $0.2 million.
The net increase in the medical market sector was $10.9 million.increased $13.0 million primarily due to increases in demand. Higher demandvolume from oura medical customer that was awaitingreleased from FDA approval inhold at the end of fiscal 2014 caused an increase of $8.8 million in the first nine months of fiscal 2015. In the second quarter of the prior fiscal year, this customer was seeking FDA approval for modifications to its existing programs which caused the programs to be put on hold. The hold was lifted during the third quarter of fiscal 2014 and the customer's testing was completed in the fourth quarter.$5.7 million. We began shipping production orders late in the fourth quarter of fiscal 2014 and volume continued to increase throughout fiscal 2015. A net increase of $3.7 million was due to higher demand from two of our customers partially offset by decreased demand from another customer. $2.6 million of the increase was due to programs at three of our customers that were in the prototype stage and ramping in fiscal 2015. An additional increase of $0.9 million was due to a new program for an existing customer.

Various increases and decreases for our aerospace & defense customers resulted in a net increase of $4.3 million. Programs frequently fluctuate in demand or end and are replaced by new programs. Aggregate increases of over $10 million were partially offset by approximately $6 million in decreases from other customers. Increases were primarily due to higher demand at several existing customers. New programs from existing customers increased revenue by an additional $2.1 million. These increases were offset by decreases at other customers. Lower demand from several of our customers caused decreases of $5.0 million. The loss of a program decreased revenue by $0.9 million.

The net decrease in revenue in the industrial market sector of $11.3 million resulted primarily from decreases in demand of $11.7 million. The majority of the decrease was anticipated during 2015 as one of our customers began sourcing more product from an alternate source in China. We expect this customer to continue to source product from China for programs we are currently supporting. A lost customer decreased revenue by $0.2 million. The decreases were partially offset by increased demand from two other customers of $0.7 million.



Gross profit for the first nine months increased to 17.3% of sales versus 11.9% in the first nine months of the prior fiscal year. Several factors impacted gross margin including improved leverage on fixed manufacturing costs caused by higher production volume, changes in customer mix and improved labor efficiencies. Higher sales and increased production to meet the higher levels of finished goods required by certain customers improved our leverage of fixed costs. Lower labor costs were due to the continued focus on lean manufacturing. Higher costs in the prior year were driven by higher labor costs due to the hiring and training for programs for customers ramping early in fiscal 2015 as well as stock compensation costs of $0.7 million in overhead due to the change in control in the second quarter of fiscal 2015. In addition, various overhead expenses were lower in the first nine months of fiscal 2015. Revenue for another medical customer increased $1.12016 when compared with the same period of fiscal 2015 including excess and obsolete inventory expense, manufacturing supplies, depreciation and consulting.

Selling and administrative (“S&A”) expense is presented excluding Restatement and related expenses discussed below. S&A expense decreased $2.1 million due to higher demand. New programs at an existing customer caused increases of $0.9$11.2 million, and fluctuations in demand caused the remaining net increase.
The net increase in the industrial market sectorrepresented 11.4% of $1.4 million resulted from increases of $3.8 million partially offset by lower customer demand. New programs with existing customers resulted in an increase of $3.1 million. We expect the volume for some of these new programs to decrease as our customers plan to source a portion of the programs from another contract manufacturer. Demand for existing programs at other customers increased revenue by $0.3 million and new customer increased revenue $0.2 million. Demand fluctuations from four of our customers caused a decrease of $1.2 million. In addition, $0.8 million of the decrease was due to a one time order in the prior fiscal year.
Gross profitsales in the first nine months of fiscal 2015 decreased $1.3 million over2016. For the first nine months of the prior fiscal year, and represents 10.7%S&A expense was $13.3 million or 14.2% of revenue comparedsales. The decrease in S&A expense was primarily due to 11.8% of revenue$3.3 million in costs in the same prior fiscal year period ofassociated with the prior year proxy contest and resulting change in control. Partially offsetting this decrease was additional severance of $0.5 million, an increase in bad debt expense of $0.2 million, legal and other professional expenses related to debt refinancing in the first quarter of fiscal year. This decrease is primarily due to lower leverage of overhead at our Albuquerque2016 and SCB operating locationsother matters as well as higher excess and obsolete inventory expense at one of our operating locations. Additional stock-based compensation attributed to the changean increase in control resulting from the proxy contest caused gross profit to decrease $0.7 million or 0.7 percentage points. The remaining difference can be attributed to better performance at our remaining operating locations, primarily as a result of improvedother labor management, leveraging of overhead due to increased revenue mainly from our medical market sector and improved material cost reductions.
Selling and administrative ("S&A") expenses are presented excluding restatement and related expenses and impairment of goodwill and other intangibles discussed below. S&A expenses increased $3.4 million, and represented 14.6% of sales overcosts for the first nine months of fiscal 2015, compared to 10.9% of sales in the same period in prior fiscal year. The increase in S&A expenses was primarily due to expenses related to the proxy contest and resulting change of control. These costs totaled $3.3 million and include stock based compensation of $1.1 million, legal and other expenses incurred by the Company and Vintage Opportunity Fund, LP of $1.5 million and severance costs of $0.8 million. Excluding these costs, S&A expense increased $0.1 million, and represented 11.2% of sales over the first nine months of fiscal 2015, compared to 11.0% of sales in the same period of the prior fiscal year.

During the third quarter of fiscal 2015, we recorded an impairment charge of $4.1 million to our SCB reporting unit which fully impaired goodwill and intangibles and impaired fixed assets by $0.1 million. IEC received an offer to purchase substantially all the assets and the assume certain liabilities of SCB for approximately $2.5 million during the third quarter of fiscal 2015. As we were willing to accept $2.5 million, we considered this to be an indication of fair value and as such, adjusted the reporting unit's assets to fair value.2016.

Restatement and related expenses of $0.9 million in the first nine months of fiscal 2015 represent third party legal and accounting fees directly attributable to the Restatements as well as other matters arising from the Prior Restatement including those more fully described in Note 17—Litigation. WeDuring the first nine months of fiscal 2016, restatement and related expenses were almost completely offset by insurance reimbursements. During the first nine months of fiscal 2015, Restatement and related expenses due to the Prior Restatement, net of insurance reimbursement were $0.3 million and an additional $0.6 million of Restatement and related expenses were for the reaudit of fiscal 2014 due to the 2014 Restatements. As discussed in Note 17—Litigation we have reached a settlement with the SEC and therefore do not anticipate significant continued legal expenses due to the Prior Restatement and other matters (including the formal SEC investigation) going forward.

Interest expense decreased by $0.3 million compared to the first nine months of the prior fiscal year. The primary reasons for the foreseeable future. While we anticipate certain of these expenses will continue to be reimbursed, any such reimbursementdecrease were lower weighted average outstanding debt for future expenses will vary with the circumstances under which such expenses are incurred and their respective amounts. $0.6 million of Restatement and related expenses in the first nine months of fiscal 2015 were for the reaudit of fiscal 2014 due to the 2014 Restatements.
Interest expense2016 and covenant waiver fees in the first nine months of fiscal 2015 increased by $0.1 million compared to the same period of the prior fiscal year. The increase is due to the net impact of adjusting the interest rate swap to fair value and an increase in the covenant waiver fee inDuring the first nine months of the current fiscal year compared to the prior fiscal year period. The weighted average

34



interest rate on IEC'sthere were no debt excluding the impactcovenant waiver fees, but we paid debt covenant waiver fees of the interest rate swap, was consistent$150.0 thousand in the first nine months of the prior fiscal year. Our average outstanding debt balances declined from $35.4decreased by $5.6 million forin the first nine months of fiscal 20142016 compared to $32.1 million for the first nine months of fiscal 2015. Average borrowingsThese decreases were partially offset by the increase in interest rate on IEC's debt, excluding the impact of the interest rate swap, of 0.17% during the first nine months of fiscal 2016 compared to the first nine months of the prior fiscal year. The net impact of adjusting the interest rate swap to fair value in the first nine months of fiscal 2015 were lower than2016 was equivalent to the same period of the prior fiscal year due to repayments on term debt. Cash paid for interest was approximately $1.2 million for the first nine months of both fiscal 2015 and fiscal 2014.year.  Detailed information regarding our borrowings including a summary of modifications in the Fourth Amended and Restated Credit Facility Agreement and debt covenant compliance, is provided in Note 8—Credit Facilities.
There was no material income tax expense or benefit in the first nine months of fiscal 2016 or fiscal 2015 as we have NOL carryforwards to offset any current tax expense and a full valuation on all deferred tax assets. As part of our 2014 Restatements as described in Note 2—Restatement of Deferred Tax Asset Valuation Allowance and Excess and Obsolete Inventory Reserve, a full valuation allowance was recorded in the second quarter of fiscal 2014.
 
With respect to tax payments, in the near term, IEC expects to be sheltered by sizable NOL carryforwards for federal income tax purposes. At the end of fiscal 2014,2015, the NOL carryforwards amounted to approximately $16.3$35.8 million. The NOL carryforwards expire in varying amounts between 2021 and 2025, with a small portion expiring in 2034,2026, unless utilized prior to these dates.

Discontinued operations is further discussed in Note 2—SCB Divestiture and Discontinued Operations. There was no loss on discontinued operations in the the first nine months of fiscal 2016. The loss on discontinued operations was $5.7 million in the first nine months of fiscal 2015.

Liquidity and Capital Resources
 
Capital Resources
 
As of June 26, 2015July 1, 2016, there were no outstanding capital expenditure commitments were $0.1 million for manufacturing equipment and building improvements.equipment.  We generally fund capital expenditures with cash flow from operations and our revolving credit facility.
 


Summary of Cash Flows
 
A summary of selected cash flow amounts for the nine months ended follows:
 
 Nine Months Ended Nine Months Ended
Cash Flow Data June 26,
2015
 June 27,
2014
 July 1,
2016
 June 26,
2015
(in thousands)   (restated)    
Cash and cash equivalents, beginning of period $1,980
 $2,499
 $407
 $1,980
Net cash flow from:  
  
  
  
Operating activities (946) 4,045
 12,250
 (894)
Investing activities (1,771) (3,483) (2,165) (1,823)
Financing activities 1,027
 (2,382) (9,889) 1,027
Net (decrease) increase in cash and cash equivalents (1,690) (1,820) 196
 (1,690)
Cash and cash equivalents at end of period $290
 $679
 $603
 $290
 
Operating activities
 
Cash flows usedprovided by continuing operations, before considering changes in IEC’s working capital accounts, was $0.9$7.5 million for the first nine months of fiscal 2015.2016.  Cash flow providedused by operations, before considering changes in working capital, in the first nine months of fiscal 20142015 was $1.2$0.7 million.  ThereNet income from continuing operations of $4.6 million in the first nine months of fiscal 2016 was an improvement incompared to the net loss from continuing operations of $5.8$4.6 million compared toduring the first nine months of the prior fiscal year, howeverand non-cash expenses were lower in the first nine months of fiscal 2015. Deferred tax expense decreased by $13.0 million compared to fiscal 2014 due to a recording a full valuation allowance on deferred tax asset in the second quarter of fiscal 2014 as further discussed in Note 2—Restatement of Deferred Tax Asset Valuation Allowance and Excess and Obsolete Inventory Reserve. In the first nine months of fiscal 2015, a $4.1 million impairment charge was taken. Stock based compensation was also higher in the first nine months of fiscal 2015 by $1.6 million as a result of the change in control resulting from the proxy contest.

Working capital did not provide or use cash flows in the first nine months of fiscal 2015 and provided cash flows of2016. Total non-cash expenses were $2.9 million in the first nine months of fiscal 2014.  The change in working capital2016 compared to $5.2 million in the first nine months of fiscal 2015.

Working capital from continuing operations provided cash flows of $4.7 million and used cash flow of $1.0 million in the first nine months of fiscal 2016 and 2015, respectively. The change in working capital in fiscal 2016 was primarily due to an increasea decrease in accounts receivable and inventory of $4.9$5.6 million partiallyand $5.7 million, respectively, offset by an increasea decrease in accounts payable and customer deposits of $3.5 million. Approximately $2.9$4.7 million and $2.6 million, respectively. Accounts receivable decreases were primarily due to timing of therevenue and improved cash collections. The decrease in accounts payable was due primarily to a reduction of inventory increase was driven by purchases related to materials management programs for several customers, mostas well as timing of which is offset by customer deposits. Increasespurchases and payments. The decrease in inventory were also causedduring the first nine months of fiscal 2016 was due to a focus on reducing raw materials and work in process inventory partially offset by increased demand including the ramp in production of relatively new customers in our medical market sector, maintaining higher levels of finished goods forrequired by certain customers at their request and delays in some smaller programs. A decrease in accounts receivablemedical customers.

35



contributed $1.4 million to cash flow provided by operations, mainly due to lower sales volume in the last two month of the third fiscal quarter of 2015 compared to the last two months of the fourth fiscal quarter of 2014 as well as improved collection of receivables. An increase in other current assets was offset by increased other accrued expenses, both primarily attributable to Restatement and related expenses and the partial reimbursement of those expenses.
Investing activities
 
Cash flows used inby investing activities for continuing operations were $1.8$2.2 million and $3.5$1.8 million for the first nine months of fiscal 20152016 and 2014,2015, respectively.  Cash flows used in the first nine months of fiscal 2016 consisted of the purchases of equipment and capitalized software costs resulting from the ongoing implementation of a new enterprise resource planning system. Cash used in the first nine months of fiscal 2015 primarily consisted of the purchases of equipment and to a lesser extent, building improvements totaling $2.5 million,capitalized software costs partially offset by cash received from a$0.7 million of community development block grant of $0.7 million. The community development block grant was initiated in fiscal 2012 but not completed and submitted for reimbursement until September 2014. Cash used in the first nine months of fiscal 2014 primarily consisted of the Celmet building purchase of $1.3 million and purchases of equipment. proceeds.

Financing activities
 
Cash flows used in financing activities were $9.9 million for the first nine months of fiscal 2016 compared to cash flows provided by financing activities wereof $1.0 million for the first nine months of fiscal 2015 and cash flows used in financing activities were $2.4 million for the first nine months of fiscal 2014.2015.  During the first nine months of fiscal 2015,2016, net borrowingsrepayments under all credit facilities were $1.6$9.7 million, with $3.8$7.2 million of net borrowingsrepayments under the revolverRevolver, as defined below, and repayments of $2.2$2.5 million for term debt. In the first nine months of fiscal 2014,2015, net cash flows reducedincreased outstanding credit facilities by $2.3$1.6 million, due to net repayments funded by operations.borrowings. 

Credit Facilities
 
At June 26, 2015,July 1, 2016, borrowings outstanding under the revolving credit facility (“Revolver”) under the Fifth Amended and Restated Credit Agreement (“Fifth Amended Credit Agreement”) amounted to $11.2$5.2 million, and the maximum available was $19.5$17.7 million.  BorrowingsRepayments on the Revolver during the current fiscal year were used to fund working capital changesdriven by cash flow from operations discussed above.  The Company believes that its liquidity is sufficient to satisfy anticipated operating requirements during the next twelve months. The Company plans to extend the maturity of its revolver, which is currently set to mature in January 2016. Should we be unable to extend the maturity or refinance our debt, we may not be able to fund our operating requirements.
 


The 2013Fifth Amended Credit Agreement also contains various affirmative and negative covenants including financial covenants. The Company is required to maintain (i) a minimum level of quarterly EBITDARS ("EBITDAS, as defined below (“Quarterly EBITDARS"EBITDAS”), (ii) a ratio of total debt to twelve month EBITDARSEBITDAS (“Debt to EBITDARSEBITDAS Ratio”) that is below a specified limit, and (iii) a minimum fixed charge coverage ratio (“Fixed Charge Coverage Ratio”), (iv) a maximum level of inventory (“Maximum Inventory”), and (v) a maximum amount of capital expenditures (“Maximum Capital Expenditures”). The Debt to EBITDARSEBITDAS Ratio is the ratio of debt to earnings before interest, taxes, depreciation, amortization rent expense and non-cash stock compensation expense.expense (“EBITDAS”). The Fixed Charge Coverage Ratio compares (i) 12 month EBITDA plus non-cash stock compensation expense minus unfinanced capital expenditures minus cash taxes paid, to (ii) the sum of interest expense, principal payments sale-leaseback payments and dividends, if any (fixed charges). Subsequent amendments toThe Maximum Inventory covenant allows for specific levels of inventory as defined by the 2013 Credit Agreement modified financialagreement. The Maximum Capital Expenditures covenants and related definitions, as described in Note 8—Credit Facilities.allow for a maximum amount of capital expenditures on an annual basis.

A summary of financial covenant compliance follows:

  Quarterly EBITDARSEBITDAS Debt to EBITDARSEBITDAS Ratio Fixed Charge Coverage RatioMaximum InventoryMaximum Capital Expenditures
Fiscal Quarters      
Third 20152016 Compliant Compliant CompliantCompliantMeasured Annually
Second 20152016 WaivedCompliant WaivedCompliant WaivedCompliantCompliantMeasured Annually
First 20152016 WaivedCompliant WaivedCompliant WaivedCompliantCompliantMeasured Annually
       
Fourth 20142015CompliantCompliant Compliant Not MeasuredApplicable Not MeasuredApplicable
Third 20142015 (1)
CompliantCompliant Compliant Not MeasuredApplicable Not MeasuredApplicable
Second 20142015 (1)
WaivedWaived Waived Not MeasuredApplicable Not MeasuredApplicable
First 20142015 (1)
WaivedWaived Waived Not MeasuredApplicable Not MeasuredApplicable

(1) The Company was subject to the 2013 Agreement during these periods.

As a result of the 2014 Restatements as described in Note 2—Restatement1—Our Business and Summary of Deferred Tax Asset Valuation Allowance and Excess and Obsolete Inventory Reserve,Significant Accounting Policies, the Company was in default of the Credit Agreement for failure to deliver financial statements prepared in accordance with GAAP.GAAP, for each of the quarters of fiscal 2014 and the fiscal quarter ending December 26, 2014. The Company received a waiver from M&T regarding this event of default.

36



The calculation of debt covenants follows:
 Limit at Calculated Amount At  Limit at Calculated Amount At
Debt Covenant June 26,
2015
 September 30,
2014
 June 26,
2015
 September 30,
2014
  July 1,
2016
 September 30,
2015
 July 1,
2016
 September 30,
2015
       (restated)        
Quarterly EBITDARS (000s) Minimum $1,250 Minimum $1,500 $1,806
 $2,641
 
Debt to EBITDARS Ratio Maximum 5.75x Not Measured 5.1x
 Not Measured
(a)
Quarterly EBITDAS (000s) Minimum $1,800 Minimum $1,500 $2,877 $2,067
Debt to EBITDAS Ratio Maximum 3.65x Maximum 5.75x 2.0x 5.2x
Fixed Charge Coverage Ratio (b)(a) Minimum 0.6x Not Measured 0.9x
 Not Measured
(a) Minimum 1.10x Minimum 0.45x 1.7x 0.8x
Maximum Inventory Maximum $28.0m Not applicable $21.8m Not applicable
Maximum Capital Expenditures Maximum $4.5m annually Not applicable Measured Annually Not applicable

(a)Compliance waived.
(b)TheAt September 30. 2105, the ratio compares (i) 12-month EBITDA plus non-cash stock compensation expense, plus permitted fiscal 2013 restatement related expenses minus unfinanced capital expenditures minus cash taxes paid ("(“Adjusted EBITDA"EBITDA”), to (ii) the sum of interest expense, principal payments sale-leaseback payments and dividends, if any (fixed charges). The Fifth Amended Credit Agreement removed the add-back of Prior Restatement related expenses.
 


A reconciliation of EBITDARSEBITDAS to Net income follows:
 Three Months Ended Three Months Ended
 June 26,
2015
 September 30,
2014
 July 1,
2016
(in thousands)   (restated)  
Net income/(loss) $(4,017) $1,034
 $1,605
Restatement related expenses (a) 
 
Asset impairment (b) 4,057
 
Restatement and related expenses 200
 
Lender requirement expenses 100
 
Provision for/(benefit from) income taxes 
 (161) (6)
Depreciation and amortization expense 1,112
 1,218
 727
Interest expense 316
 386
 389
Non-cash stock compensation 38
 164
 162
EBITDARS $1,806
 $2,641
EBITDAS $2,877
 
A reconciliation of Adjusted EBITDA to Net income follows: 
 Three Months Ended  Three Months Ended
 June 26,
2015
 September 30,
2014
  July 1,
2016
(in thousands)   (restated)
   
Net income/(loss) (4,017) $1,034
  1,605
Restatement related expenses (a) 
 
 
Asset impairment (b) 4,057
 
 
Restatement related expenses (a) 200
 
 
Lender requirement expenses 100
 
 
Provision for/(benefit from) income taxes 
 (161)  (6)
Depreciation and amortization expense 1,112
 1,218
  727
Interest expense 316
 386
  389
Non-cash stock compensation 38
 164
  162
Unfinanced capital expenditures (563) (512)  (895)
Income taxes paid 
 (3)  
Adjusted EBITDA $1,243
 $2,126
  $1,982

EBITDARSEBITDAS and Adjusted EBITDA are non-GAAP financial measures.  They should not be considered in isolation or as a measure of the Company’s profitability or liquidity; are in addition to, and are not a substitute for, financial measures under GAAP.  EBITDARSEBITDAS and Adjusted EBITDA may be different from non-GAAP financial measures used by other companies, and

37



may not be comparable to similarly titled measures reported by other companies.  Non-GAAP financial measures have limitations since they do not reflect all of the amounts associated with the Company’s results of operations as determined in accordance with GAAP. 
 
EBITDARSEBITDAS and Adjusted EBITDA do not take into account working capital requirements, capital expenditures, debt service requirements and other commitments, and accordingly, EBITDARSEBITDAS and Adjusted EBITDA are not necessarily indicative of amounts that may be available for discretionary use.  We present EBITDARSEBITDAS and Adjusted EBITDA because certain covenants in our credit facilities are tied to these measures.  We also view EBITDARSEBITDAS and Adjusted EBITDA as useful measures of operating performance given our large net operating lossNOL carryforward and because, as supplemental measures: (i) they are a basis upon which we assess our liquidity position and performance and (ii) we believe that investors will find the data useful in assessing our ability to service and/or incur indebtedness.  We believe that EBITDARSEBITDAS and Adjusted EBITDA, when considered with both our GAAP results and the reconciliation to net income, provide a more complete understanding of our business than could be obtained absent this disclosure. 
 
Off-Balance Sheet Arrangements
 
IEC is not a party to any material off-balance sheet arrangements.
 
Application of Critical Accounting Policies
 
Our application of critical accounting policies are disclosed in our 20142015 Annual Report on Form 10-K/A10-K filed for the fiscal year ended September 30, 2014.2015.  During the nine months ended June 26, 2015July 1, 2016 there have been no material changes to these policies.
 


Recently Issued Accounting Standards
 
See Note 1—Our Business and Summary of Significant Accounting Policies for further information concerning recently issued accounting pronouncements.
 
Item 3.    Quantitative and Qualitative Disclosures About Market Risk
 
As a result of its financing activities, the Company is exposed to changes in interest rates that may adversely affect operating results. The Company actively monitors its exposure to interest rate risk and from time to time uses derivative financial instruments to manage the impact of this risk.  The Company uses derivatives only for the purpose of managing risk associated with underlying exposure.  The Company does not trade or use instruments with the objective of earning financial gains on the interest rate, nor does the Company use derivatives instruments where it does not have underlying exposure.  The Company manages its hedging position and monitors the credit ratings of counterparties and does not anticipate losses due to counterparty nonperformance.  Management believes its use of derivative instruments to manage risk is in the Company’s best interest.  However, the Company’s use of derivative financial instruments may result in short-term gains or losses and increased volatility.
 
At June 26, 2015,July 1, 2016, the Company had $33.0$21.6 million of debt, comprised of $24.5$16.7 million with variable interest rates and $8.5$4.9 million with fixed interest rates.  Interest rates on variable loans are based on London interbank offered rate (“Libor”LIBOR”). The Company is party to a swap transaction that effectively fixes an additional $10.7$9.2 million of debt, which increased the portion of debt with effectively fixed interest rates from $8.5$4.9 million to $19.2$14.1 million at June 26, 2015.July 1, 2016. The credit facilities and related swap transaction are more fully described in Note 8—Credit Facilities and Note 9—Derivative Financial Instruments.  The rates effectively fixed by the swap transaction continue to vary due to the variable margin based on financial covenant metrics. Interest rates based on LiborLIBOR currently adjust daily, causing interest on such loans to vary from period to period.  A sensitivity analysis as of June 26, 2015July 1, 2016 indicates that a one-percentage point increase or decrease in our variable interest rates, which represents more than a 10% change, would increase or decrease the Company's annual interest expense by approximately $0.2 million. The rates and sensitivity analysis noted above exclude the impact of the swap transaction.Swap Transaction.
 
The Company is exposed to credit risk to the extent of non-performance by M&T Bank under the 2013 Credit Agreement and the Swap Transaction.  M&T Bank's credit rating (reaffirmed A-A by Fitch in October 2014)2015) is monitored by the Company, and IEC expects that M&T Bank will perform in accordance with the terms of the 2013Fifth Amended Credit Agreement and the Swap Transaction.
 
Item 4.    Controls and Procedures
 
Evaluation of disclosure controls and procedures
 

38



IEC’s management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(c) and 15d-15(c) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of June 26, 2015,July 1, 2016, the end of the period covered by this Form 10-Q.  Based on that evaluation, solely as a result of the material weaknessesweakness related to user access reviews and reconciliation of accounts receivable discussed in greater detail in our Form 10-K/A10-K filed with the SEC on May 11,December 18, 2015 (the “2014“2015 Form 10-K/A”10-K”), our Chief Executive Officer and Chief Financial Officer concluded that as of June 26, 2015,July 1, 2016, the Company’s disclosure controls and procedures were not effective. To address thesethis material weaknesses,weakness, we have implemented certain remedial measures, as described below and in our 20142015 Form 10-K/A.10-K.
 
Changes in internal control over financial reporting
 
Management identified material weaknesses in our internal control over financial reporting related to an error in the valuation allowance on deferred income tax assetsuser access reviews and an error in estimated excess and obsolete inventory reserves,reconciliation of accounts receivable, as discussed in greater detail in Item 9A of our 20142015 Form 10-K/A.10-K. To address thesethis material weaknesses,weakness, we have implemented certain remedial measures, as described in Item 9A of our 20142015 Form 10-K/A,10-K, which description is incorporated by reference herein. TheBased on this evaluation, we consider the material weaknesses cannot be consideredweakness related to user access reviews and the reconciliation of accounts receivables not to have been fully remediated untiland still present at July 1, 2016 as management has not yet been able to conclude, through testing, that the applicable remedial controls operatehave operated effectively for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.time.
Except as described above, during the nine months ended June 26, 2015,July 1, 2016, there were no changes in our internal controls that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 
 


Limitations on the effectiveness of control systems
 
IEC’s management does not expect that our disclosure controls and internal controls will prevent all errors and fraud. Because of inherent limitations in any such control system (e.g. faulty judgments, human error, information technology system error, or intentional circumvention), there can be no assurance that the objectives of a control system will be met under all circumstances. Moreover, projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. The benefits of a control system also must be considered relative to the costs of the system and management’s judgments regarding the likelihood of potential events. In summary, there can be no assurance that any control system will succeed in achieving its goals under all possible future conditions, and as a result of these inherent limitations, misstatements due to error or fraud may occur and may or may not be detected.

39




Part II        OTHER INFORMATION
 
Item 1.    Legal Proceedings
 
The Company previously restated its consolidated financial statements for the fiscal year ended September 30, 2012, and the interim fiscal quarters and year to date periods within the year ended September 30, 2012, included in the Company’s Annual Report on Form 10-K/A, and the fiscal quarter ended December 28, 2012, as reported in the Company’s Quarterly Report on Form 10-Q/A for that fiscal quarter (the “Prior Restatement”). On June 28, 2016, the Company consented to the entry of a settled administrative order by the SEC alleging violations of the antifraud, periodic and current reporting, internal controls, and books-and-records provisions of the federal securities laws. As part of the settled administrative order, the Company (i) neither admitted nor denied the SEC’s findings, (ii) paid a penalty of $200,000, and (iii) agreed to cease-and-desist from committing or causing any violations or future violations of those provisions. In addition, the settled administrative order included settled charges and sanctions against two individuals who are no longer associated with the Company - a former Executive Vice President of the Company and a former Controller of SCB that was the subject of the Prior Restatement.

In connection with the Prior Restatement, W. Barry Gilbert, our former chief executive officer and director, voluntarily returned to the Audit Committee conducted an independent reviewCompany certain incentive compensation and the proceeds from certain sales of the underlying factsCompany's common stock. These transfers, which were made during the three months ended January 1, 2016, were in the form of cash of $42 thousand and circumstances, andshares of common stock valued at $60 thousand.

Effective March 16, 2016, the Company is respondingentered into a separation agreement with Mr. Gilbert (the “Separation Agreement”). Pursuant to a formal investigation by the staffterms of the SECSeparation Agreement, Mr. Gilbert received a separation benefit of $500 thousand that was paid on March 16, 2016 and $200 thousand paid on May 16, 2016, and he will receive $100 thousand payable on both March 16, 2017 and March 16, 2018, and $75 thousand payable on each of March 16, 2019 and March 16, 2020. The separation benefit is subject to acceleration in the event of certain changes in control of the Company. The Company also released Mr. Gilbert from any and all claims and causes of action directly or indirectly related to Mr. Gilbert’s employment relationship with the Company. In consideration of the foregoing, Mr. Gilbert agreed to release the Company from any and all claims and causes of action arising out of or relating to his previous employment with the Prior Restatement andCompany, as well as certain other matters. The Company is unable to predict what action, if any, might be takencovenants set forth in the future by the SEC or its staff as a result of the investigation or what impact the cost of responding to the SEC might have on the Company’s financial position, results of operations, or cash flows.Separation Agreement.

From time to time, the Company may be involved in other legal action in the ordinary course of its business, but management does not believe that any such other proceedings commenced through the date of the financial statements included in this Form 10-Q, individually or in the aggregate, will have material adverse effect on the Company’s consolidated financial position.

Item 1A.   Risk Factors
 
Except as set forth below, thereThere have been no material changes from the risk factors as previously disclosed in our Annual Report on Form 10-K/A10-K for the year ended September 30, 20142015 filed with the Securities and Exchange CommissionSEC on May 11,December 18, 2015.
OUR OPERATING RESULTS AND FINANCIAL CONDITION COULD BE ADVERSELY AFFECTED IF WE ARE UNABLE TO EXTEND THE MATURITY DATE OF THE REVOLVER OR REFINANCE THE REVOLVER ON FAVORABLE TERMS.The Revolver matures on January 18, 2016, and all amounts outstanding under the Revolver will be due and payable upon maturity. At June 26, 2015, borrowings outstanding under the Revolver amounted to $11.2 million. We anticipate that we will be able to enter into a new revolving credit facility with M&T Bank or extend the maturity date of the Revolver prior to January 18, 2016. If we are unable to enter into a new revolving credit facility with M&T Bank or extend the maturity date of the Revolver prior to the maturity date, we anticipate that we would be able enter into a new revolving credit facility with a different lender. However, there can be no assurance financing will be available when needed and, if such financing is available, it may only available on terms that are less favorable to us. Our financial condition, results of operations and future prospects could be adversely impacted if we are unable to obtain financing on favorable terms.

Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds:

None

Item 3.    Defaults Upon Senior Securities
 
None
 
Item 4.    Mine Safety Disclosures
 
Not Applicable
 
Item 5.    Other Information:

None
 
Item 6.    Exhibits
 
For the exhibits that are filed herewith or incorporated herein by reference, see the Index to Exhibits located immediately following the signature page to this Report.  The Index to Exhibits is incorporated herein by reference.


40




SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
  IEC Electronics Corp.
  (Registrant)
   
August 5, 201510, 2016By:/s/ Jeffrey T. Schlarbaum
  Jeffrey T. Schlarbaum
  President & Chief Executive Officer and President
   
August 5, 201510, 2016By:/s/ Michael T. Williams
  Michael T. Williams
  Vice President of Finance and Chief Financial Officer
 

41




IEC ELECTRONICS CORP.
Form 10-Q for Quarter Ended June 26, 2015July 1, 2016
INDEX TO EXHIBITS
 
Exhibit No. Description
   
2.13.1 Asset Purchase Agreement, effective July 9, 2015 between Southern California Braiding, Inc. and DCX-Chol Enterprises, Inc.Bylaws, as amended through May 12, 2016 (incorporated herein by reference from Exhibit 3.1 to the Company's Current Report on Form 8-K filed May 18, 2016).
10.1 SixthFirst Amendment to FourthFifth Amended and Restated Credit Facility Agreement dated as of May 8, 2015,June 20, 2016 by and between IEC Electronics Corp. and Manufacturers and Traders Trust Company (incorporated herein by reference infrom Exhibit 10.610.1 to the Company's QuarterlyCompany’s Current Report on Form 10-Q8-K filed on May 11, 2015).June 24, 2016)
10.2Confidential Settlement and Waiver/Release Agreement effective June 23, 2016 by and between the Company and Brett E. Mancini #
31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
101 The following items from this Quarterly Report on Form 10-Q formatted in Extensible Business Reporting Language: (i) Consolidated Balance Sheets (unaudited), (ii) Consolidated Income Statements (unaudited), (iii) Consolidated Statements of Changes in Stockholders' Equity (unaudited), (iv) Consolidated Statements of Cash Flows (unaudited), and (v) Notes to Consolidated Financial Statements. 

# filed herewith


4243